rfhg_47946.1

Basic information about the TSS

---

TSS ID: rfhg_47946.1 Species: human Chr: chr3		Start: 100709666 End: 100709685 Strand: +
Source datasets	FANTOM5|DBTSS
Protocol	CAGE|TSS-seq
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC023599:8 GeneID: 10342 HGNC/MGI_ID: HGNC:11758 UniProt_ID: Nearer transcript ids and distances: ENST00000463568.6:-53 ENST00000676395.1:-53 ENST00000476228.5:-60 BC041600:-60 ENST00000676111.1:-116 BC001483:-124 ENST00000675243.1:-130 LF213806:-138 MA449383:-138 ENST00000240851.9:-172 NM_001195478.2:-172 NM_001195479.2:-172 NM_006070.6:-172 ENST00000674758.1:-194 ENST00000676431.1:-203 ENST00000674615.1:-204 ENST00000675420.1:-209 BC009241:-214 ENST00000479672.6:-226 ENST00000675591.1:-226 ENST00000676010.1:-226 LF210631:-230 MA446208:-230 ENST00000674798.1:-237 ENST00000675246.1:-237 ENST00000675692.1:-237 ENST00000676276.1:-237 ENST00000676054.1:-237 ENST00000675890.1:-237 ENST00000675011.1:-237 ENST00000675586.1:-237 ENST00000674645.1:-237 ENST00000675958.1:-237 AK093456:-241 ENST00000620299.5:-252 ENST00000487505.6:285 ENST00000675553.1:-304 ENST00000418917.7:-313 ENST00000674699.1:-349 ENST00000675047.1:-371 ENST00000490574.6:-371 ENST00000675543.1:-371 ENST00000676308.1:-371 ENST00000675499.1:-371 NM_001007565.2:-376 LF339557:406 MA575134:406 view more...

Gene_name: trafficking from ER to golgi regulator Gene_symbol: TFG Gene_synonyms: FLJ36137 SPG57 TF6 Gene_source: HGNC:11758

TATA-Box annotation

---

Distance to TSS:	133
Nearest PromoterID:	NM_001195478
Entrez ID:	10342
Nearest Unigene:	Hs.518123
Nearest Refseq:	NM_006070
Nearest Ensembl:	ENSG00000114354
Gene Name:	trafficking from ER to golgi regulator
Gene Alias:	HMSNP|SPG57|TF6|TRKT3
Gene Type:	protein-coding
CpG%:	0.105263
GC%:	0.650000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TFG p2@TFG p3@TFG p4@TFG p5@TFG p6@TFG p7@TFG p8@TFG
Sample		p1@TFG	p2@TFG	p3@TFG	p4@TFG	p5@TFG	p6@TFG	p7@TFG	p8@TFG
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	75.00	6.23	1.17	14.22	9.74	6.04	0.78	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	90.84	5.46	2.43	12.14	8.50	5.66	0.61	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	92.40	6.94	3.09	18.13	9.07	5.02	0.96	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	69.44	7.90	2.49	14.55	6.65	4.37	0.42	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	84.81	6.97	2.47	14.85	8.32	4.72	0.90	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	77.91	9.30	2.33	15.89	7.95	7.75	1.16	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	89.33	3.49	2.18	18.08	9.37	7.19	0.44	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	81.39	3.39	0.97	15.02	8.96	5.57	0.24	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	72.66	2.78	0.85	15.39	11.54	6.63	0.64	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	88.68	4.64	1.16	27.82	7.54	7.54	0.58	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	89.74	7.28	1.21	21.83	7.68	6.47	2.02	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	89.85	6.50	2.85	30.90	11.38	6.91	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	44.97	8.06	4.51	1.61	0.64	1.13	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	45.86	7.52	6.01	0.90	1.95	1.50	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	39.30	7.90	4.83	0.88	0.66	1.98	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	38.98	6.04	7.29	0.75	1.51	0.75	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	34.73	6.77	6.55	1.31	0.87	1.53	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	41.34	6.75	3.37	0.84	0.84	1.69	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	31.46	9.60	4.27	0.53	1.07	2.13	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	35.96	7.07	5.72	0.75	1.20	0.75	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	44.24	9.49	7.08	1.20	0.80	1.07	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	46.09	8.46	6.90	0.86	1.90	1.04	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	37.10	8.40	5.04	0.52	0.65	1.42	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	39.31	6.31	6.07	0.49	0.73	1.70	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	36.12	7.74	6.45	1.55	1.03	0.26	1.03	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	32.60	9.18	4.75	0.63	0.95	0.32	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	40.11	12.09	5.49	0.55	1.65	1.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	38.66	9.67	8.25	0.71	0.94	1.18	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	33.11	5.17	6.30	0.97	0.81	0.81	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	41.80	10.50	7.06	1.45	1.09	0.90	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	37.26	6.91	5.86	1.26	1.26	0.42	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	37.32	7.23	4.69	1.17	2.15	0.98	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	44.32	9.92	6.12	1.27	1.90	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	55.91	11.05	9.90	1.32	0.66	1.65	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	38.52	6.73	6.36	1.12	1.50	0.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	34.88	7.09	5.56	0.96	0.38	1.34	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	38.63	6.95	4.70	1.84	1.23	0.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	31.63	8.87	5.24	1.61	0.60	1.81	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	41.06	8.37	6.75	1.62	0.81	1.08	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	45.13	7.20	5.52	0.96	0.96	0.96	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	43.76	7.06	5.65	0.94	0.71	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	54.46	8.93	10.39	0.88	1.32	1.17	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	44.08	6.75	7.38	1.05	0.63	0.84	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	44.06	6.99	5.77	0.70	2.10	1.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	45.78	10.84	5.62	1.61	2.01	1.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	47.46	8.38	5.35	0.93	0.93	0.47	0.47	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	38.62	8.88	4.56	2.40	1.44	0.72	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	50.07	11.33	6.26	1.49	0.60	0.89	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	55.06	11.97	8.14	0.96	0.24	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	50.35	13.35	7.48	2.22	2.22	1.01	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	59.03	16.40	7.58	1.43	0.61	1.02	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	72.72	18.23	14.68	1.78	1.78	0.67	0.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	321.82	181.90	153.91	13.99	0.00	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	53.23	13.48	11.00	3.90	2.13	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	76.22	15.24	11.93	0.99	1.66	0.99	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	217.28	93.12	77.18	10.07	2.52	5.03	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	112.97	49.14	33.07	3.21	0.46	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	74.54	17.83	11.02	0.65	1.30	1.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	63.27	13.17	9.96	1.28	0.00	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	92.73	42.12	29.86	1.89	1.89	0.94	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	62.75	15.51	13.40	1.41	2.12	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	57.76	16.26	16.26	1.12	2.24	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	164.01	101.91	70.86	3.98	3.18	2.39	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	84.94	42.13	25.48	1.70	1.02	1.36	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	61.09	15.92	8.12	1.95	1.30	1.62	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	56.44	16.68	11.00	1.77	1.42	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	404.10	193.97	274.79	32.33	16.16	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	481.75	252.72	197.44	23.69	7.90	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	76.05	19.99	17.06	1.95	0.00	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	58.51	17.85	13.88	1.49	1.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	72.71	16.42	9.85	0.47	1.41	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	79.49	18.88	16.56	1.32	0.66	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	65.58	18.56	14.54	1.55	0.62	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	62.07	17.73	18.96	0.92	1.83	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	128.29	17.11	5.86	1.27	0.95	0.32	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	87.91	8.02	4.33	1.44	1.12	0.16	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	129.52	23.54	7.63	2.67	0.89	0.89	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	88.20	9.72	2.99	0.75	0.00	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	56.27	4.69	3.68	2.01	0.33	0.33	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	88.04	14.67	12.12	0.00	0.64	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	30.79	6.60	3.30	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	84.91	12.19	4.06	2.26	2.71	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	57.17	3.48	1.91	1.56	1.22	0.70	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	104.04	7.63	1.76	2.93	2.93	0.39	0.00	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	63.06	4.12	2.57	2.32	2.06	1.03	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	76.66	3.07	1.67	0.56	1.67	1.95	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	67.01	4.70	0.00	1.18	1.18	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	83.25	5.15	2.01	2.57	3.30	1.13	0.24	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	49.06	1.61	1.29	0.65	2.90	0.97	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	62.38	5.87	1.60	0.53	1.60	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	73.45	3.90	1.67	1.67	1.67	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	59.89	4.99	3.74	1.25	1.25	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	58.27	2.76	2.01	1.76	2.26	0.50	0.50	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	57.92	1.31	1.31	0.33	1.96	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	47.80	2.44	2.13	0.30	1.83	1.22	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	107.18	11.27	6.85	5.75	5.30	1.55	0.22	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	67.77	3.59	1.79	0.36	0.72	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	45.52	2.40	1.20	2.40	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	141.05	15.11	20.15	3.06	2.34	0.90	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	85.35	11.71	16.73	1.67	0.00	3.35	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	138.47	12.94	10.68	1.85	1.03	0.21	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	94.29	18.65	12.59	2.86	2.29	3.43	0.34	0.69
Anulus Pulposus Cell, donor2	11463-119B5	68.33	10.04	9.06	1.47	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	70.54	11.23	7.64	2.25	4.04	0.00	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	89.43	11.72	5.64	1.30	1.30	0.00	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	59.93	10.70	4.28	2.14	0.00	4.28	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	81.61	10.16	6.28	0.90	0.90	1.20	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	104.97	13.91	3.79	1.26	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	66.01	6.60	2.64	1.32	0.00	2.64	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	76.67	12.02	5.85	0.65	2.60	0.32	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	75.73	11.65	8.74	0.97	0.97	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	62.95	12.47	5.94	0.59	1.19	1.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	80.98	18.83	6.78	0.75	0.75	0.75	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	82.73	8.71	5.81	1.45	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	61.44	7.52	3.76	0.00	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	91.10	14.33	7.91	1.65	0.99	0.66	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	90.08	9.55	12.28	1.36	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	71.93	11.91	5.13	1.51	0.45	0.45	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	84.65	9.11	7.50	0.00	1.61	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	79.16	13.79	8.12	1.13	1.13	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	88.74	12.83	6.68	0.53	1.34	0.27	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	75.11	12.68	10.73	0.98	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	71.32	11.61	8.13	1.16	1.16	0.83	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	43.23	10.81	7.20	1.20	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	106.20	10.62	21.24	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	77.70	12.86	9.26	1.20	0.86	0.51	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	67.12	20.97	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	77.18	15.05	10.19	1.46	2.43	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	66.78	13.66	11.00	1.52	0.00	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	53.30	10.90	3.63	1.21	2.42	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	84.94	11.97	11.40	0.57	2.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	68.41	13.04	7.27	1.71	0.86	0.64	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	58.59	8.78	4.90	1.03	0.52	1.03	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	79.77	11.26	9.38	0.94	1.88	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	74.60	12.54	6.43	1.93	0.96	1.29	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	52.80	11.42	4.99	1.43	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	72.53	13.45	8.77	1.75	2.34	2.92	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	80.39	9.94	7.83	1.20	0.90	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	59.40	11.88	4.75	0.00	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	70.69	9.15	9.66	1.53	2.03	1.53	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	72.33	10.95	6.11	1.02	0.00	0.76	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	68.62	6.35	4.45	2.54	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	83.29	9.93	4.75	0.43	1.73	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	75.57	11.64	8.04	0.85	1.69	0.85	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	58.58	7.83	6.38	0.87	0.87	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	85.97	13.23	4.72	0.00	1.89	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	82.39	11.70	6.10	2.03	1.19	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	55.59	18.53	6.95	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	95.07	16.90	2.11	0.00	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	69.26	13.08	8.36	1.72	1.07	1.50	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	63.17	13.84	7.22	0.00	0.00	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	66.34	13.12	13.85	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	63.68	15.40	12.41	1.15	0.69	1.38	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	53.56	25.50	12.75	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	81.86	21.10	7.63	1.78	0.76	0.25	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	80.30	15.48	11.35	0.83	0.21	0.62	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	72.52	11.02	5.20	0.61	0.00	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	85.09	21.51	11.47	1.91	0.96	1.91	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	79.38	14.63	13.53	1.11	0.22	1.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	67.14	30.52	12.21	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	75.88	14.40	8.31	1.66	2.22	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	81.03	15.62	11.92	2.91	1.06	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	69.06	11.63	11.63	1.45	0.73	1.09	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	119.25	7.86	6.88	4.91	3.44	3.07	0.49	0.86
Astrocyte - cerebellum, donor2	11580-120F5	82.67	6.85	6.85	1.37	1.03	1.03	0.51	0.17
Astrocyte - cerebellum, donor3	11661-122F5	78.03	3.99	1.47	2.94	3.99	3.99	0.84	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	91.68	8.37	8.37	7.32	13.94	7.67	1.74	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	83.96	5.50	4.21	6.47	5.50	5.01	0.81	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	104.41	6.12	2.68	8.50	10.59	7.91	1.49	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	115.14	9.29	4.24	9.17	6.42	5.50	0.92	1.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	132.80	8.90	5.39	10.52	6.01	6.77	0.63	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	108.11	9.56	3.87	7.06	5.80	6.60	0.80	0.68
Basophils, donor1	12241-129G9	32.43	3.92	3.66	2.09	0.78	2.35	0.52	0.00
Basophils, donor2	12242-129H1	51.23	9.38	1.80	3.25	3.25	4.33	1.08	0.36
Basophils, donor3	12243-129H2	41.60	5.59	2.06	1.91	2.65	0.73	0.15	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	83.44	8.62	3.02	1.51	1.94	0.86	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	40.69	2.74	1.83	0.00	0.00	0.00	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	86.08	7.17	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	54.61	3.14	0.63	2.51	1.26	2.51	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	69.46	3.33	1.25	2.08	1.66	1.04	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	102.94	6.68	2.76	3.68	1.61	0.46	0.69	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	76.84	4.32	2.52	3.06	2.52	1.08	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	20.61	0.41	0.10	7.73	3.61	6.29	1.13	1.03
Burkitt's lymphoma cell line:RAJI	10476-106I8	30.74	0.93	0.00	3.03	3.26	2.33	1.40	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	59.80	1.28	0.00	4.16	4.80	5.12	0.64	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	0.00	0.00	0.00	10.34	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	37.19	6.20	1.69	2.82	1.69	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	47.33	5.20	2.04	1.30	1.11	1.48	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	39.74	8.56	4.39	0.88	2.63	0.66	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	73.87	2.26	0.28	0.85	5.09	1.70	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	66.72	2.65	1.90	2.27	3.41	1.14	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	85.14	0.99	1.97	1.64	1.31	0.66	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	46.26	3.18	1.30	0.72	3.18	0.29	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	38.92	3.62	0.30	0.91	3.92	0.00	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	63.01	4.26	1.18	0.71	4.97	0.47	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	50.72	2.85	1.34	1.51	2.68	0.00	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	33.95	2.76	0.83	0.00	1.10	0.00	0.00	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	57.52	5.70	2.48	1.98	1.74	0.25	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	78.32	2.94	2.35	3.52	4.90	0.00	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	59.47	3.74	1.96	2.14	5.52	0.18	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	136.24	10.88	5.01	8.05	10.23	0.44	0.00	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	41.91	3.75	0.70	1.40	1.87	0.47	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	44.88	6.34	2.11	1.58	2.64	0.53	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	56.58	9.98	3.33	4.44	3.33	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	41.05	2.83	1.78	0.59	2.23	0.15	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	35.52	3.39	0.20	0.20	2.79	0.20	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	68.50	6.45	3.75	2.29	5.20	0.42	0.00	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	46.90	2.06	0.92	1.37	3.20	0.46	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	41.17	4.52	1.81	1.81	2.26	0.00	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	52.38	3.49	1.31	1.31	3.93	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	76.93	5.38	1.08	1.08	4.84	0.54	0.00	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	78.33	6.63	1.74	1.22	6.11	0.35	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	130.03	13.47	3.37	3.37	9.26	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	49.05	1.65	1.47	1.10	4.04	0.00	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	36.64	1.06	0.35	2.47	3.87	0.00	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	60.98	3.07	0.88	5.70	7.46	0.00	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	62.25	5.41	1.57	1.74	4.88	0.52	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	64.30	5.20	1.86	2.23	5.95	0.37	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	119.85	15.74	5.17	6.68	10.13	0.86	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	58.15	2.05	2.05	3.28	3.28	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	42.42	3.25	0.46	2.78	4.64	0.00	0.00	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	71.45	8.35	1.39	4.18	3.94	0.70	0.00	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	43.37	1.31	0.22	1.09	4.58	0.22	0.44	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	50.59	2.77	1.15	1.85	1.62	0.69	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	44.62	2.38	0.22	0.43	2.82	1.08	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	54.81	1.09	0.78	0.62	1.87	0.47	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	48.55	2.27	0.70	0.52	3.32	0.00	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	69.57	1.78	1.11	0.67	2.01	0.45	0.22	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	32.92	0.77	0.00	1.28	3.32	0.51	0.00	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	38.20	0.88	0.22	1.54	5.05	1.10	0.22	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	40.00	1.05	0.21	1.47	6.32	1.05	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	36.58	2.03	0.00	16.26	6.10	16.26	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	27.80	0.68	0.00	16.27	6.10	16.27	5.42	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	30.03	0.00	0.00	15.53	7.25	10.36	5.18	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	30.92	1.07	0.53	12.26	6.40	13.33	5.33	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.41	2.14	0.00	14.47	4.29	20.37	4.29	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	30.18	0.70	0.00	11.93	4.21	13.34	2.81	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	23.53	0.00	0.78	18.82	3.92	11.77	4.71	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	32.96	1.32	0.00	13.18	6.59	17.14	5.27	0.00
CD19+ B Cells, donor1	11544-120B5	32.88	2.47	0.82	6.58	5.75	7.40	4.11	0.00
CD19+ B Cells, donor2	11624-122B4	38.45	5.08	2.90	5.08	5.08	10.16	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	35.34	3.03	1.01	8.08	7.07	10.10	2.52	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	93.34	3.64	1.62	15.35	11.31	10.10	2.83	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	76.70	2.80	0.80	12.38	11.59	3.20	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	51.21	2.01	0.00	5.02	3.01	6.02	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	70.23	8.99	3.93	5.62	2.81	5.62	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	55.99	1.50	1.13	6.39	5.26	6.76	0.00	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	63.14	1.80	1.58	6.31	5.19	6.31	1.13	0.45
CD4+ T Cells, donor1	11225-116C1	44.28	0.71	1.79	10.71	8.57	8.93	2.50	0.36
CD4+ T Cells, donor2	11306-117C1	54.50	0.61	0.00	6.74	4.90	7.96	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	38.12	1.83	0.91	5.49	4.27	8.23	1.52	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	53.09	1.02	0.00	6.89	7.40	7.40	1.28	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	53.90	0.22	0.00	6.51	7.64	6.29	1.80	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	45.42	0.86	0.29	5.17	4.02	5.17	2.59	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	37.45	0.00	0.00	10.90	6.64	14.22	2.84	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	46.35	0.70	0.00	9.83	5.62	16.86	4.92	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	0.00	0.00	13.18	6.59	13.18	3.30	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	54.05	0.00	0.29	5.35	3.90	6.50	1.30	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	43.21	0.17	0.00	4.74	4.58	6.10	1.02	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	42.88	0.81	0.16	4.67	4.19	5.96	1.29	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	30.48	0.90	0.00	6.72	7.17	13.45	1.34	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	51.01	0.35	0.00	8.39	4.89	12.23	2.45	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	40.04	0.44	0.00	9.68	5.72	14.08	6.16	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	69.57	0.42	0.00	4.64	5.48	6.32	1.69	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	57.34	1.04	0.21	3.53	5.19	2.91	0.42	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	47.78	1.67	0.00	2.67	4.01	3.68	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	35.35	0.27	0.00	9.25	5.71	10.88	1.36	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	42.34	0.00	0.54	10.72	9.65	10.18	2.14	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	52.00	0.00	0.00	7.17	7.17	8.97	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	61.01	0.74	0.00	4.64	5.19	5.19	1.85	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	43.97	1.30	0.22	6.50	5.85	5.20	1.08	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	48.55	0.42	0.21	7.36	7.57	5.04	1.47	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	45.50	0.00	0.00	6.57	4.04	5.06	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	38.13	0.43	0.00	5.63	6.50	8.67	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	56.66	0.00	0.00	8.28	8.28	3.92	1.31	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	52.46	0.00	0.00	17.32	8.41	13.36	3.46	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	40.62	0.00	0.00	11.08	8.31	12.00	4.62	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	43.27	0.00	0.00	15.35	6.98	8.37	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	58.16	1.38	0.00	13.57	6.37	9.97	6.09	2.22
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	64.54	0.25	0.25	15.46	5.64	12.76	5.40	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	52.36	0.00	0.00	12.32	4.62	1.54	4.62	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	54.08	0.00	0.00	11.82	4.66	12.89	4.30	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	55.40	1.38	0.00	8.31	5.54	9.69	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	42.89	1.64	0.00	3.93	3.27	7.53	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	54.44	2.63	0.38	3.38	5.26	6.01	1.88	0.00
CD8+ T Cells, donor3	11383-118B6	47.72	1.77	1.01	4.04	5.55	4.80	1.51	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	82.35	13.76	6.42	2.29	2.75	0.23	0.00	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	75.25	16.77	4.31	2.64	1.44	0.48	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	80.16	12.86	3.83	2.46	1.37	0.00	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	96.37	21.01	6.90	3.60	3.00	0.90	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	95.03	15.12	3.84	2.16	3.60	0.00	0.48	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	89.14	15.46	2.96	2.27	3.87	0.45	0.23	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	70.62	17.82	7.17	2.17	3.48	0.65	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	72.91	12.90	7.11	0.79	3.68	0.53	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	84.43	16.65	7.74	1.41	3.75	0.23	0.00	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	76.07	19.32	6.94	2.11	3.32	0.60	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	77.86	16.56	7.26	2.32	2.32	0.58	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	75.40	22.65	5.60	2.13	3.46	0.80	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	79.67	21.45	8.32	2.19	2.63	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	85.62	20.95	6.83	1.82	3.64	0.00	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	62.65	11.19	9.70	0.75	2.98	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	99.40	15.49	6.84	2.88	5.76	0.36	0.00	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	92.93	15.54	7.48	3.16	3.45	0.58	0.00	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	88.86	18.15	5.19	2.83	4.71	0.24	0.00	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	107.11	19.65	6.02	2.22	2.22	1.27	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	82.43	15.69	9.84	1.23	3.08	1.23	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	86.88	20.52	6.41	2.56	3.85	0.32	0.00	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	88.35	20.27	7.27	1.53	2.29	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	78.82	19.31	3.55	2.76	2.76	1.18	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	65.81	12.86	6.81	5.29	1.51	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	159.79	23.29	6.42	5.62	3.21	2.41	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	157.37	21.68	6.29	9.79	2.80	0.00	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	150.26	34.06	6.01	11.02	6.01	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	40.21	0.00	1.83	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	70.16	9.39	3.46	0.00	1.48	1.48	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	102.18	10.00	7.16	2.00	1.47	0.63	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	123.41	15.95	18.72	4.16	1.73	0.69	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	71.43	13.15	6.75	1.42	0.36	1.42	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	86.24	10.70	5.58	0.91	1.14	0.57	0.23	0.00
Chondrocyte - re diff, donor2	11339-117F7	242.61	41.18	39.39	5.37	0.90	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	104.74	12.13	10.51	0.40	1.62	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	121.41	11.25	5.28	6.20	4.25	6.31	0.80	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	82.09	12.18	8.76	3.21	1.92	1.07	0.64	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	102.21	11.77	7.17	2.12	2.30	1.15	0.53	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	79.60	16.14	9.54	6.69	5.69	4.40	1.28	0.64
Corneal Epithelial Cells, donor1	11526-119I5	99.69	4.61	1.98	2.63	2.42	0.66	0.22	0.66
Corneal Epithelial Cells, donor2	11606-120I4	116.04	2.28	1.14	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	101.74	5.88	1.79	5.11	3.07	0.77	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	62.74	4.13	1.32	0.66	0.83	0.50	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	52.99	2.84	1.89	0.95	0.95	0.32	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	106.97	10.35	6.90	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	56.26	2.38	1.73	1.19	0.97	0.11	0.22	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	43.73	0.68	1.37	7.86	16.74	6.49	1.37	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	50.27	0.65	0.00	18.93	10.45	6.53	1.31	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	44.52	0.00	0.00	16.45	8.71	5.32	0.00	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	90.06	4.50	3.00	4.17	3.67	1.00	0.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	56.92	7.04	1.76	1.17	1.17	0.59	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	69.29	6.22	7.64	2.55	3.68	0.85	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	69.20	5.50	2.36	1.18	1.18	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	59.92	6.69	4.65	3.49	3.20	0.87	0.00	0.87
Endothelial Cells - Artery, donor2	11341-117F9	93.64	7.29	6.82	4.24	4.00	1.41	0.24	0.47
Endothelial Cells - Artery, donor3	11413-118E9	85.38	4.21	2.45	2.45	4.03	0.70	0.00	1.58
Endothelial Cells - Lymphatic, donor1	11236-116D3	78.02	9.31	3.77	1.77	1.55	0.44	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	132.96	12.17	7.91	3.35	3.04	0.91	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	117.84	15.22	8.74	4.23	4.51	0.85	0.85	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	68.64	8.02	4.75	0.89	1.78	1.19	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	74.46	6.77	4.17	1.56	1.56	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	45.94	5.81	4.25	1.13	0.85	0.57	0.00	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	106.03	14.80	9.20	5.20	4.80	1.60	1.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	78.62	5.77	5.77	0.00	1.05	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	141.77	11.06	7.83	8.32	5.59	4.47	0.75	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	63.01	1.96	3.48	3.48	3.04	1.30	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	89.40	3.05	1.59	4.64	2.81	2.81	0.61	0.24
Endothelial Cells - Vein, donor1	11267-116G7	47.78	4.55	1.14	3.41	0.00	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	62.17	3.49	2.10	2.10	4.19	2.10	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	77.25	3.30	2.36	2.51	3.61	1.57	0.16	0.63
Eosinophils, donor1	12244-129H3	152.47	15.25	15.25	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	219.48	49.51	14.85	4.95	3.30	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	153.37	64.20	10.70	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	83.32	3.66	1.71	1.95	2.69	0.24	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	60.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	162.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	94.42	19.29	15.60	1.64	0.41	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	43.90	9.85	4.49	0.66	0.22	0.55	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	75.84	12.57	6.83	1.19	0.87	0.87	0.00	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	117.40	21.71	17.22	3.40	1.94	1.46	0.00	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	136.33	21.97	10.92	3.28	1.09	0.55	0.14	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	89.33	16.35	6.86	1.37	0.95	0.63	0.21	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	89.32	11.86	8.43	1.58	0.26	0.53	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	99.33	12.29	10.30	1.66	1.99	1.99	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	81.65	11.79	9.98	1.81	0.45	1.36	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	70.49	15.16	3.79	5.31	6.06	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	64.35	17.66	12.93	1.42	1.42	0.32	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	130.03	16.97	13.34	3.33	1.82	2.42	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	97.46	13.45	11.17	2.54	1.27	1.02	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	91.11	9.55	6.37	3.64	1.06	1.36	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	141.36	17.82	8.31	8.44	1.21	1.74	0.27	2.41
Fibroblast - Choroid Plexus, donor2	11572-120E6	64.28	8.63	9.06	6.04	3.88	5.18	1.73	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	109.86	4.39	5.86	2.93	4.39	2.93	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	178.05	5.77	3.46	9.23	11.99	2.54	0.23	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	129.07	15.26	10.69	2.04	2.37	1.53	0.34	0.00
Fibroblast - Dermal, donor1	11269-116G9	75.36	9.16	7.28	3.05	3.29	0.94	0.23	0.47
Fibroblast - Dermal, donor2	11346-117G5	76.88	6.13	2.83	3.30	3.77	1.89	0.94	0.94
Fibroblast - Dermal, donor3	11418-118F5	77.49	9.43	5.08	1.81	1.21	0.73	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	147.86	6.33	2.83	9.83	6.33	4.18	0.79	0.57
Fibroblast - Dermal, donor5	11454-119A5	129.62	4.19	2.44	7.33	5.06	3.84	1.40	0.17
Fibroblast - Dermal, donor6	11458-119A9	132.86	5.85	2.60	7.80	4.06	2.11	0.32	0.65
Fibroblast - Gingival, donor1	11237-116D4	125.56	14.16	13.12	3.96	3.75	2.29	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	101.13	16.77	7.86	1.05	1.05	1.31	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	104.11	6.59	3.95	4.09	3.16	2.24	0.40	0.66
Fibroblast - Gingival, donor3	11394-118C8	114.57	9.38	8.70	3.48	3.87	2.61	0.10	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	112.20	9.35	9.35	4.16	5.19	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	82.82	8.81	6.34	2.47	1.59	1.06	0.53	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	112.25	8.89	3.74	3.43	2.49	1.25	0.47	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	96.69	10.95	5.14	2.43	2.43	1.62	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	46.58	5.65	3.88	1.76	2.12	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	121.09	14.77	6.73	3.51	2.34	0.88	0.15	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	111.13	14.86	5.45	3.14	2.86	1.36	0.55	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	112.98	14.37	4.61	3.95	2.41	1.43	0.11	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	107.71	8.07	4.40	1.32	2.35	1.76	0.44	0.15
Fibroblast - Lung, donor1	11270-116H1	29.91	1.36	1.36	0.00	1.36	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	104.45	7.46	10.45	2.98	2.98	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	83.99	8.02	4.43	2.11	2.74	1.90	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	204.09	17.49	6.66	3.33	0.00	1.67	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	92.31	8.39	4.20	0.00	1.40	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	50.10	2.80	2.24	0.56	1.12	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	267.94	29.23	13.40	6.90	10.56	2.44	0.41	1.22
Fibroblast - Mammary, donor2	11620-122A9	95.86	11.98	0.00	3.99	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	119.13	5.96	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	125.69	6.21	2.72	9.12	8.34	4.46	0.39	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	147.13	6.52	3.03	8.65	7.74	5.46	0.46	1.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	186.35	14.38	15.30	7.65	5.51	5.81	0.61	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	81.67	6.11	4.96	2.67	3.05	0.00	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	92.88	14.31	5.40	2.97	2.16	0.54	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	74.11	6.03	5.10	1.39	1.51	0.70	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	107.66	15.59	9.28	2.65	2.10	1.77	0.33	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	181.25	29.46	19.71	4.67	5.89	1.22	0.41	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	77.51	6.01	4.01	3.34	2.67	2.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	73.93	5.14	6.33	2.37	2.37	1.98	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	129.59	13.10	8.73	3.18	1.98	1.19	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	99.64	15.63	8.70	1.78	2.66	1.24	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	123.77	18.92	6.11	2.17	3.35	1.38	0.20	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	114.93	12.94	6.32	2.11	2.41	1.50	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	143.14	20.51	11.66	3.45	2.27	1.30	0.65	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	142.73	22.78	9.11	0.51	0.25	0.51	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	115.51	26.91	9.68	1.64	1.48	1.48	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	134.54	11.83	10.43	3.61	2.81	2.01	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	127.69	27.23	14.97	2.41	0.70	1.21	0.30	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	185.27	19.04	12.39	2.12	3.63	1.21	1.21	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	114.00	16.98	7.79	2.57	1.74	1.41	0.25	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	167.36	24.45	10.26	2.56	1.03	1.20	0.34	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	121.19	17.74	7.55	1.31	1.31	0.99	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	125.27	23.33	10.33	2.24	1.28	1.81	0.64	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	118.41	14.00	7.08	4.22	4.72	3.20	0.51	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	109.62	19.92	11.29	2.82	0.31	0.47	0.47	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	576.15	110.80	177.28	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	73.21	0.87	3.49	2.61	4.36	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	135.91	14.56	5.72	3.81	2.08	1.04	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	146.52	22.38	14.83	5.73	1.56	1.30	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	123.16	17.37	13.80	4.34	2.56	2.30	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	68.13	1.53	0.00	11.48	7.66	7.66	2.30	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	68.27	0.64	1.91	15.95	6.38	11.49	1.91	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	64.75	1.43	1.14	19.68	10.55	11.41	1.43	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	66.73	7.17	3.86	10.48	8.82	5.52	1.65	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	56.40	6.62	2.97	8.22	5.02	3.88	0.23	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	54.68	1.59	0.59	11.89	12.28	6.34	1.39	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	59.48	2.91	3.70	8.72	8.46	7.67	2.11	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	63.92	5.22	3.91	3.26	6.85	4.24	1.96	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	49.97	1.77	0.88	15.04	7.96	8.40	2.65	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	58.22	2.40	1.13	6.08	11.31	6.22	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	62.80	4.31	2.09	4.68	6.90	6.53	1.48	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	55.61	2.42	1.07	13.97	9.40	5.10	1.88	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	57.36	5.70	1.73	6.69	9.04	4.21	1.24	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	56.62	3.05	0.97	7.48	10.24	4.98	1.94	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	43.30	2.24	1.63	6.91	8.13	4.27	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	52.71	3.88	1.14	4.79	4.79	4.79	0.68	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	49.95	4.48	1.37	3.74	5.98	3.11	1.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	46.78	2.40	0.66	5.46	5.03	2.84	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	61.46	5.02	2.36	5.91	5.91	3.55	0.89	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	64.06	5.72	2.86	5.25	8.11	5.40	1.27	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	62.33	4.24	2.46	6.93	4.92	3.57	1.12	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	75.01	3.63	3.23	5.44	6.05	4.03	1.41	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	77.87	10.35	2.71	5.60	9.84	4.75	1.36	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	87.34	15.61	5.14	8.96	6.56	6.30	1.51	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	118.42	9.78	4.99	12.07	11.34	8.84	1.25	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	95.46	9.91	4.27	12.47	11.44	7.51	2.56	1.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	73.70	6.53	4.09	4.76	5.53	5.75	1.44	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	89.60	13.15	4.74	10.32	6.82	5.07	1.41	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	86.57	12.66	6.74	7.55	6.94	4.49	1.23	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	67.05	6.19	2.89	3.09	7.63	4.13	1.24	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	73.10	8.07	3.69	5.42	8.42	6.00	0.81	1.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	65.87	6.84	2.67	4.34	6.34	4.00	0.67	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	61.06	3.75	2.42	3.31	3.53	4.63	1.98	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	79.82	8.24	3.32	4.92	6.64	5.04	0.74	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	70.51	4.54	3.40	6.00	4.86	2.59	1.30	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	71.52	4.81	4.49	3.85	8.34	3.53	1.28	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	67.18	5.59	2.65	4.64	5.40	3.70	0.66	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	65.01	4.59	2.21	2.53	4.43	3.80	0.32	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	64.77	6.08	3.34	2.43	3.95	4.26	0.61	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	71.40	7.00	3.87	3.55	5.65	2.61	0.63	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	63.67	5.93	1.54	1.76	4.61	2.42	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	74.63	8.98	2.52	2.24	4.49	4.77	1.12	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	73.70	9.26	4.26	2.87	3.24	2.50	0.65	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	63.64	7.75	4.28	3.74	5.08	1.34	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	70.69	7.19	3.83	3.06	3.21	2.60	0.46	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	81.87	9.20	4.66	3.37	3.63	1.94	0.39	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	77.53	8.13	4.61	1.90	2.17	1.36	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	90.33	9.59	6.45	2.95	3.13	1.66	0.74	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	81.80	7.46	6.14	2.41	2.63	1.32	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	116.03	12.89	7.93	2.98	1.98	7.93	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	99.59	11.34	5.41	2.11	2.37	2.77	0.53	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	90.79	8.07	3.63	2.22	3.63	0.40	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	315.16	42.44	26.43	15.00	6.61	12.96	1.78	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	64.50	0.80	1.00	17.12	9.75	10.35	2.79	2.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	49.30	0.77	0.77	5.55	12.48	6.01	1.54	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	46.03	0.61	0.41	12.89	21.07	11.87	3.07	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	73.85	5.95	1.88	17.52	15.02	9.07	0.94	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	54.82	1.70	1.13	15.26	16.95	5.65	1.13	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	49.81	0.92	1.84	6.46	11.53	9.69	0.92	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	4.95	2.47	7.42	12.37	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	65.76	5.80	3.09	11.22	10.06	6.58	0.77	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	73.81	9.63	3.21	4.81	8.02	4.81	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	53.90	3.48	1.74	6.96	3.48	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	62.17	6.84	2.93	12.69	10.09	5.86	1.30	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	68.77	7.00	1.65	5.77	9.06	5.35	1.65	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	3.33	3.33	23.33	6.66	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	68.79	5.59	4.47	7.27	6.15	5.87	0.84	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	68.96	6.86	3.92	9.15	6.86	6.86	1.31	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	55.36	3.36	2.52	5.87	5.87	3.36	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	69.66	9.54	1.91	9.86	7.00	6.68	0.00	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	60.80	5.43	3.06	8.83	9.85	4.08	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	2.09	4.18	8.35	10.44	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	69.30	6.30	4.01	5.73	6.30	6.87	1.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	61.56	5.33	6.22	3.85	10.06	3.85	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	55.91	8.47	6.78	6.78	8.47	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	91.13	10.36	6.63	4.97	7.04	4.56	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	77.32	12.20	7.13	9.44	6.90	6.90	0.92	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	21.07	10.54	10.54	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	70.73	8.46	8.84	4.23	9.99	5.00	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	78.56	10.43	8.15	2.61	3.26	2.93	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	73.57	8.69	4.01	4.01	4.01	9.36	1.34	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	82.06	10.79	3.47	3.08	6.55	5.39	1.93	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	125.30	27.04	18.14	13.01	7.87	7.19	3.08	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	62.12	2.48	4.97	0.00	2.48	9.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	67.47	9.91	7.08	7.55	6.13	7.08	1.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	78.45	9.05	5.43	8.45	10.86	3.62	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	76.81	13.73	8.65	7.63	8.65	5.09	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	80.17	8.77	9.57	5.58	5.58	5.98	1.20	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	74.00	12.83	7.89	4.93	5.43	5.92	1.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	89.71	7.08	4.72	5.90	11.80	5.90	3.54	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	76.43	7.58	9.34	2.92	5.25	5.25	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	91.73	10.97	7.90	7.02	6.58	4.39	2.63	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	74.60	20.34	9.32	4.24	5.09	9.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	81.78	17.91	12.54	3.58	3.58	1.79	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	73.76	14.07	7.76	1.46	1.46	2.43	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	60.49	11.41	13.70	0.00	2.28	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	83.16	9.56	3.33	0.42	0.83	0.83	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	87.71	7.87	1.12	2.25	5.62	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	90.39	8.56	4.12	1.90	0.63	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	66.84	8.77	2.51	0.84	0.42	2.09	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	96.78	14.62	6.15	6.15	3.37	2.09	0.58	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	103.64	16.54	7.60	6.92	4.90	2.19	0.51	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	102.15	12.97	5.69	5.92	3.87	2.05	0.68	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	96.85	13.99	4.92	4.59	2.84	2.95	0.33	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	107.03	15.47	5.37	5.59	3.44	2.36	0.64	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	101.18	9.69	5.81	5.81	3.23	3.44	0.22	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	90.41	14.20	5.23	5.48	2.74	3.36	0.25	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	97.78	12.18	4.29	6.52	3.60	1.89	0.17	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	81.69	14.42	6.41	5.13	4.81	3.52	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	71.63	3.92	2.80	1.68	0.56	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	88.72	2.60	2.16	2.16	4.76	1.73	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	71.38	10.58	0.00	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	131.21	15.17	10.23	1.06	1.06	0.71	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	93.72	10.90	5.09	0.73	2.91	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	75.36	10.14	10.67	1.57	1.57	0.35	0.35	0.00
Hepatocyte, donor1	11523-119I2	95.64	6.05	6.05	2.42	4.84	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	175.61	16.16	4.31	5.39	7.54	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	93.26	14.11	5.52	4.91	3.68	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	45.04	0.00	0.00	9.14	8.48	4.57	0.00	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	231.24	30.06	6.47	11.54	4.89	3.15	1.40	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	96.18	19.76	12.76	2.06	2.20	1.23	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	0.00	0.00	3.18	9.55	6.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	6.68	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	34.61	4.15	1.38	1.38	2.77	0.00	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	0.00	0.00	0.00	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00	11.87	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	2.56	2.56	2.56	0.00	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	0.00	0.00	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	48.73	3.25	1.62	8.12	1.62	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	18.34	1.67	3.33	1.67	0.00	5.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	3.63	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	31.76	2.65	1.32	5.29	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	41.02	0.00	0.00	0.00	2.22	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	26.45	2.52	0.63	3.78	3.15	1.26	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	3.09	0.00	6.19	4.64	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	14.63	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	29.07	2.58	0.65	0.00	2.58	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	0.00	0.00	3.22	1.61	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	11.95	23.90	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	37.48	1.63	0.81	2.44	1.63	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	30.23	6.30	0.42	2.10	3.78	0.42	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	33.75	1.61	1.61	1.61	3.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	28.62	1.85	0.00	6.46	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.51	1.89	0.94	1.89	2.83	1.89	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.05	2.72	1.81	2.72	2.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	25.83	6.46	1.08	3.23	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	22.87	1.27	0.00	3.81	1.27	1.27	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	29.33	4.46	0.64	1.28	1.28	1.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	30.99	1.82	1.82	0.00	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	24.28	5.00	4.28	1.43	2.14	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	0.00	3.32	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	35.19	6.48	2.16	2.16	1.85	0.93	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	0.00	1.76	1.76	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	40.86	3.14	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.73	0.70	1.39	2.78	2.78	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	4.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	3.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	16.57	1.74	0.87	0.00	0.87	0.87	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	0.00	0.00	2.25	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	0.00	0.00	3.48	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	21.34	2.13	1.07	0.00	4.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	0.00	0.00	0.00	4.16	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	2.85	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	27.61	0.00	1.84	0.00	0.00	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	0.00	0.00	6.05	6.05	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	22.20	1.06	2.11	3.17	1.06	1.06	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	163.04	16.32	5.06	4.24	1.63	1.39	0.08	0.49
Keratinocyte - epidermal, donor2	11349-117G8	64.42	6.44	3.51	1.17	1.17	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	125.51	8.61	2.18	4.73	2.65	1.14	0.19	0.57
Keratinocyte - oral, donor1	11251-116E9	156.77	10.22	5.68	5.11	4.77	2.61	0.23	0.23
Keratocytes, donor1	11527-119I6	169.51	6.53	3.09	5.50	10.66	4.47	0.00	0.00
Keratocytes, donor2	11607-120I5	110.15	5.86	5.86	7.03	8.20	1.17	0.00	3.52
Keratocytes, donor3	11688-122I5	81.41	2.96	1.19	1.78	1.58	0.00	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	46.16	0.00	0.00	2.20	8.79	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	76.59	6.47	0.00	3.24	1.08	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	94.69	14.88	10.50	4.84	8.53	5.19	1.04	1.61
Lens Epithelial Cells, donor3	11690-122I7	85.87	13.52	10.39	1.92	2.12	1.72	0.40	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	97.23	6.40	2.73	3.44	4.15	1.66	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	64.75	4.74	2.51	1.95	1.40	1.67	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	91.14	5.35	2.36	2.05	2.20	2.05	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	62.37	4.30	0.54	1.08	1.61	1.61	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	61.46	5.36	2.52	1.89	3.47	1.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	66.52	5.18	1.40	1.94	1.29	0.65	0.22	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	72.64	5.34	2.46	1.64	1.23	0.41	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	58.65	4.30	3.03	2.28	1.26	1.26	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	69.95	6.05	2.82	2.25	1.13	0.56	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	65.66	6.33	1.98	3.56	1.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	65.34	5.04	3.10	2.91	2.13	2.52	0.00	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	51.47	3.15	2.96	0.56	1.11	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	76.65	5.57	3.48	3.14	1.39	1.39	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	65.36	3.10	1.43	2.62	1.19	0.00	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	59.33	3.85	3.71	2.06	1.24	0.82	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	81.30	4.31	2.77	1.85	1.85	1.54	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	48.63	3.74	2.49	1.56	1.56	1.56	0.31	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	77.59	6.22	1.46	2.56	1.65	0.73	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	62.53	3.62	3.62	1.65	0.33	1.97	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	66.48	4.98	2.05	0.59	0.88	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	59.25	5.97	2.24	1.24	1.24	1.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	64.50	3.39	2.91	2.91	0.00	0.97	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	61.40	5.12	2.96	4.85	0.54	1.08	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	69.18	6.96	2.12	2.42	1.51	1.51	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	68.43	5.18	1.56	4.15	2.07	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	71.40	6.70	4.61	2.30	1.05	1.26	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	68.72	5.56	2.26	1.65	0.75	1.20	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	78.42	2.75	0.69	0.69	1.38	2.06	0.00	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	61.90	6.02	4.33	2.26	1.32	0.94	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	59.48	4.77	2.54	1.70	0.74	0.95	0.11	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	66.39	6.78	2.42	2.42	2.91	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	56.90	4.96	2.32	3.64	0.33	1.98	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	60.83	5.08	2.97	1.73	1.61	0.87	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	78.85	4.81	2.22	2.59	2.96	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	61.28	5.68	2.22	3.71	0.99	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	56.23	4.81	2.20	1.24	1.10	1.24	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	74.30	6.75	5.15	1.61	2.25	1.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	78.82	4.56	3.35	5.48	1.52	1.22	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	81.04	6.02	3.08	3.08	1.12	1.54	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	69.33	5.33	1.07	3.20	2.84	1.78	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	50.90	6.79	2.91	3.39	0.97	1.45	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	56.33	5.45	1.71	0.93	1.87	1.09	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	80.22	6.45	3.22	3.58	3.58	2.51	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	62.39	4.90	2.61	4.25	0.98	3.27	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	53.91	4.24	2.35	1.41	1.88	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	100.24	9.53	4.33	3.59	3.59	2.23	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	47.64	5.38	3.84	1.79	1.54	1.54	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	67.13	4.77	4.77	1.49	0.30	0.60	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	90.64	4.53	0.00	0.00	0.00	4.53	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	57.53	3.07	0.77	2.30	3.07	3.84	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	58.64	5.20	2.97	5.20	2.23	2.23	2.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	58.81	4.23	0.85	2.96	3.81	0.42	0.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	58.38	2.81	2.11	3.52	2.11	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	56.97	5.60	1.87	0.93	1.87	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	49.98	5.15	1.55	1.55	2.06	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	44.01	3.57	1.19	2.38	4.76	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	51.12	3.85	0.68	2.71	3.39	1.81	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	74.74	5.82	3.78	0.87	1.74	1.45	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	79.68	8.10	2.25	3.60	4.50	2.70	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	72.08	10.30	2.71	3.39	2.98	3.66	0.68	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	61.11	8.22	2.05	4.11	2.57	2.57	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	61.75	6.35	1.76	2.82	1.41	2.47	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	61.30	5.33	2.00	2.67	1.33	2.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	72.84	8.66	1.53	1.53	2.55	3.57	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	66.43	10.14	1.60	3.74	2.67	2.13	0.80	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	62.16	7.37	2.08	2.08	3.21	3.59	0.57	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	63.20	5.52	0.61	4.29	1.23	3.07	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	65.23	9.79	1.63	2.45	3.26	0.82	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	64.14	7.08	2.71	2.08	3.54	3.12	1.04	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	58.29	8.97	3.64	3.36	4.48	2.52	1.40	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	71.09	9.27	3.09	2.06	3.09	4.12	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	66.48	5.81	2.61	2.32	1.16	1.45	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	71.15	6.88	2.69	3.29	0.90	3.29	0.60	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	69.16	2.21	4.43	2.77	2.21	6.09	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	65.04	8.48	3.18	2.12	1.77	2.12	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	55.32	7.74	2.58	2.95	3.32	1.84	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	57.56	4.61	2.30	2.30	5.76	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	61.02	5.76	1.92	3.45	2.30	2.30	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	60.01	6.79	1.70	2.83	1.70	2.26	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	59.07	5.74	4.92	0.82	0.82	3.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	71.40	7.23	1.81	1.36	2.26	0.90	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	53.86	6.46	3.59	5.03	2.87	2.15	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	88.13	7.47	2.99	2.24	3.73	2.99	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	64.66	11.15	2.23	3.34	1.49	0.74	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	63.75	8.18	1.29	4.74	2.58	3.02	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	56.52	9.42	1.71	2.57	5.14	2.57	0.00	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	68.97	5.66	2.67	2.67	1.67	1.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	63.95	6.64	1.21	1.81	3.02	1.81	1.81	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	52.61	4.27	3.55	0.00	2.13	0.71	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	51.56	5.50	2.75	1.37	2.41	3.09	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	66.02	5.90	1.07	0.54	1.61	1.61	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	61.28	2.69	2.02	1.35	4.71	3.37	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	78.53	7.04	1.85	1.85	1.48	2.59	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	76.75	5.81	4.65	1.16	1.16	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	66.64	8.46	1.06	1.06	3.17	0.00	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	67.23	6.40	1.20	2.80	1.20	2.80	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	59.60	5.09	0.00	3.63	1.45	2.91	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	52.12	3.83	1.53	0.00	2.30	3.83	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	60.18	5.92	1.97	2.47	1.48	0.49	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	61.16	3.76	1.88	3.76	0.94	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	51.29	5.53	1.51	2.51	5.03	2.01	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	61.74	4.51	1.80	3.15	2.70	2.25	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	60.24	3.44	1.72	1.72	3.44	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	59.68	7.13	1.34	1.34	1.78	4.01	1.78	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	64.91	5.87	2.74	1.96	1.56	3.52	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	61.36	4.62	1.32	1.32	1.98	1.98	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	70.05	8.82	1.04	4.15	3.11	5.19	0.00	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	84.89	11.38	3.50	4.38	1.31	3.50	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	72.12	7.27	0.56	3.35	1.68	3.91	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	62.71	7.95	1.77	2.65	4.86	2.65	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	78.30	6.17	3.47	3.86	2.70	0.39	1.16	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	60.26	6.08	4.05	5.57	3.54	1.52	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	72.09	8.65	1.92	1.92	4.81	1.92	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	70.76	7.16	3.58	3.18	1.99	3.58	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	66.23	8.51	1.82	1.22	4.25	1.82	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	66.40	5.53	1.38	2.08	1.38	3.46	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	69.16	7.60	1.52	1.52	0.38	2.66	1.14	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	71.27	7.75	1.55	2.58	2.58	3.10	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	67.12	10.88	3.02	2.42	0.60	1.81	1.21	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	72.57	9.19	1.58	4.75	3.49	2.22	0.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	73.03	9.60	2.13	1.07	0.53	4.80	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	59.77	5.17	2.30	1.72	1.15	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	65.31	11.31	2.06	2.57	3.09	4.11	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	69.32	7.78	0.71	6.37	3.54	2.12	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	72.64	5.11	2.27	2.27	0.57	2.84	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	78.63	7.07	4.16	2.50	1.25	3.74	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	90.05	8.61	3.13	3.92	1.57	3.13	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	66.81	8.35	3.34	2.51	0.42	1.25	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	72.02	8.36	4.18	3.25	2.32	1.39	1.39	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	70.25	10.04	1.34	4.01	2.01	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	81.80	10.69	2.14	2.14	1.07	1.07	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	84.46	8.08	2.42	4.85	1.62	3.23	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	72.50	8.26	1.84	5.51	0.92	3.67	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	86.24	10.67	0.89	1.78	0.89	1.78	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	52.43	7.98	1.14	2.85	3.42	2.28	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	71.32	7.67	1.53	1.53	0.77	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	90.28	4.92	2.19	3.83	3.28	2.19	0.55	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	76.62	4.45	0.45	4.45	4.45	1.34	0.45	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	101.12	6.50	1.82	2.86	3.90	3.64	0.52	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	93.50	3.32	3.32	1.99	2.65	1.33	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	72.75	10.39	2.08	4.16	2.08	4.16	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	57.89	1.60	1.14	1.14	0.68	0.23	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	58.17	3.49	2.02	0.55	0.92	0.18	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	49.16	3.15	1.18	1.18	0.52	0.52	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	121.07	22.83	11.68	5.84	3.72	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	164.63	44.84	28.05	4.91	0.79	1.27	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	167.34	27.10	18.90	5.42	2.08	2.50	0.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	144.28	30.59	15.44	5.58	1.99	1.30	0.30	0.30
Mammary Epithelial Cell, donor2	11350-117G9	121.61	19.98	8.40	4.34	1.16	1.74	0.29	0.58
Mammary Epithelial Cell, donor3	11422-118F9	71.59	3.74	3.74	1.75	1.50	1.00	0.25	0.50
Mast cell - stimulated, donor1	11487-119E2	538.28	288.12	330.83	35.93	2.03	6.78	0.68	0.00
Mast cell, donor1	11563-120D6	108.14	21.41	22.49	2.70	2.38	1.41	0.22	0.11
Mast cell, donor2	11565-120D8	190.49	56.46	38.04	3.86	2.08	2.67	0.30	0.30
Mast cell, donor3	11566-120D9	298.52	92.98	33.77	5.40	6.08	1.35	0.45	0.45
Mast cell, donor4	11567-120E1	129.78	32.27	17.02	3.55	1.95	1.42	0.18	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	121.76	24.84	16.97	1.89	2.66	1.33	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	79.96	39.69	19.26	1.75	0.58	1.17	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	106.58	9.52	7.34	1.03	2.52	1.03	0.00	0.11
Mast cell, expanded, donor8	11941-126A6	76.65	9.21	2.68	1.51	1.17	0.84	0.17	0.17
Melanocyte - dark, donor1	11502-119F8	94.62	5.57	2.69	4.18	3.68	2.29	0.20	0.40
Melanocyte - dark, donor2	11582-120F7	70.60	5.88	4.15	1.04	1.04	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	98.30	3.77	3.26	4.64	5.72	1.45	0.14	0.29
Melanocyte - light, donor1	11274-116H5	47.72	3.53	1.88	0.47	2.59	0.47	0.00	0.24
Melanocyte - light, donor2	11351-117H1	34.81	1.36	1.36	1.36	2.05	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	33.82	2.60	0.87	0.00	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	79.97	2.19	2.39	2.39	6.14	0.94	0.21	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	68.31	6.19	3.77	1.34	1.34	1.08	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	90.80	5.89	3.48	1.07	5.36	1.61	0.00	0.27
Meningeal Cells, donor1	11493-119E8	192.29	11.54	6.95	6.70	5.09	2.73	0.25	0.62
Meningeal Cells, donor2	11573-120E7	99.03	11.88	9.24	9.24	2.64	0.88	0.00	1.76
Meningeal Cells, donor3	11654-122E7	146.38	11.33	6.19	5.30	5.05	3.99	0.49	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	106.93	7.70	3.42	3.42	3.71	3.42	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	98.02	20.83	8.96	2.11	0.81	1.01	0.30	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	28.91	2.63	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	70.64	3.92	0.00	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	69.61	4.31	5.02	0.72	3.59	2.15	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	95.51	19.69	6.99	3.60	2.12	1.27	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	75.40	15.58	7.54	1.51	0.50	1.51	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	118.01	5.71	1.98	4.40	5.05	3.08	0.44	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	103.74	5.11	2.92	5.11	3.65	2.19	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	95.75	6.14	2.25	2.66	3.48	3.07	0.20	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	125.49	18.28	7.34	1.94	0.83	1.52	0.83	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	71.37	3.35	3.72	1.12	0.74	0.37	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	142.76	17.76	7.76	1.58	2.63	0.92	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	95.55	9.79	2.97	0.89	2.37	0.59	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	42.04	4.67	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	124.88	5.12	3.20	0.64	3.84	1.28	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	91.45	5.67	2.84	6.38	6.38	1.77	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	120.09	13.45	5.32	0.94	1.56	1.25	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	70.39	3.63	1.45	3.63	3.63	0.00	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	107.13	31.29	8.22	3.71	1.33	0.80	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	91.08	21.02	10.01	2.50	2.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	88.31	16.62	6.50	1.73	1.08	0.94	0.07	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	1.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	45.31	3.69	2.46	0.49	1.48	0.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	30.62	2.65	3.53	0.59	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	36.88	3.41	1.86	0.00	0.62	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	38.79	3.94	1.66	0.21	0.21	0.41	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	0.00	0.00	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	48.80	3.50	3.00	1.00	0.25	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	30.26	1.86	1.40	2.33	0.00	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	44.91	4.27	2.64	0.41	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	38.80	4.36	1.19	0.00	0.40	0.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	32.74	0.88	2.65	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	42.55	4.56	1.52	0.76	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	22.37	0.00	1.32	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	46.05	3.18	2.55	0.21	0.85	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	27.62	0.92	0.00	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	44.41	3.58	1.19	1.19	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	1.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	44.91	4.52	2.76	0.75	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	43.26	2.85	1.90	0.95	0.00	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	22.67	1.66	0.00	0.00	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	50.19	7.14	3.45	1.61	0.92	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	48.80	4.63	2.31	0.00	0.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	45.45	4.08	1.83	0.61	0.61	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	51.06	5.58	1.50	0.86	0.43	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	48.90	5.11	1.78	1.11	0.22	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	51.69	5.48	3.50	1.10	0.66	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	32.95	2.03	2.53	0.00	0.51	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	41.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	47.84	4.35	2.17	0.82	0.82	0.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	54.70	4.41	1.47	0.88	0.88	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	32.71	2.18	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	60.07	7.69	3.84	1.44	0.96	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	60.43	7.20	2.40	1.60	1.60	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	34.28	1.37	0.00	1.37	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	64.07	4.00	5.01	2.00	2.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	28.54	2.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	82.33	11.39	5.69	1.31	2.19	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	24.28	0.00	0.00	3.31	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	28.18	1.92	0.00	1.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	88.51	9.17	3.97	0.74	2.23	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	42.45	4.18	2.09	0.00	1.39	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	2.21	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	57.09	6.50	3.42	1.71	2.05	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	27.57	0.88	0.88	0.88	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	23.79	1.07	1.78	0.00	1.07	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	63.97	8.70	5.89	1.96	3.09	0.56	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	32.83	3.74	2.91	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	21.56	1.17	0.58	1.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	54.00	7.54	5.73	0.60	2.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	52.59	8.35	4.59	0.42	1.25	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	54.49	7.39	3.69	0.00	1.85	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	49.51	7.40	4.55	0.57	1.71	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	36.76	4.56	1.11	0.41	1.24	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	59.60	5.18	6.22	1.30	2.85	0.26	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	45.47	3.43	3.00	0.43	0.43	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	22.87	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	41.37	3.74	2.67	0.80	2.40	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	58.07	5.09	3.89	0.90	0.90	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	31.08	3.25	2.40	0.28	1.55	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	57.33	6.69	5.41	1.59	0.96	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	53.07	8.18	6.86	1.11	1.33	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	28.82	2.28	2.28	0.76	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	57.39	6.53	5.68	1.42	3.13	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	65.14	6.15	6.88	0.74	0.49	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.02	0.65	0.65	1.96	1.96	1.30	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	55.28	3.53	4.70	0.59	2.06	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	66.89	5.19	7.50	1.15	1.73	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	44.10	4.95	2.47	0.41	1.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	50.92	2.68	2.08	1.19	2.68	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	1.78	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	57.17	2.63	0.66	0.99	0.99	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	37.87	2.10	1.05	0.00	1.05	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	43.49	2.57	0.59	0.59	1.38	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	65.19	0.00	0.00	2.79	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	60.46	3.76	1.13	0.75	2.25	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	35.16	3.20	0.80	0.27	1.07	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	48.41	3.73	1.58	0.45	1.24	0.23	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	39.78	1.47	0.74	0.00	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	47.27	2.56	1.83	0.37	0.73	0.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	42.00	1.56	1.56	1.56	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	66.80	3.74	1.60	0.53	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	0.00	0.00	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	43.43	5.05	1.01	1.01	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	42.59	2.95	1.26	0.42	2.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	38.13	4.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	26.07	3.81	1.27	0.64	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	41.30	3.24	1.62	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	42.29	1.51	0.00	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	85.65	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	55.46	3.26	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	9.50	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	12.55	0.00	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	125.17	37.49	23.27	4.74	2.15	0.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	108.18	15.16	7.84	2.61	1.05	2.09	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	49.39	6.67	4.00	1.33	2.67	2.67	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	58.85	5.84	2.92	0.42	1.25	0.83	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	89.56	7.99	5.13	3.80	3.42	2.09	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	49.47	4.79	1.60	0.00	6.38	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	29.24	2.04	5.44	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	297.70	40.43	27.56	7.35	1.84	12.86	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	37.67	2.51	4.60	1.67	0.84	1.26	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	59.04	8.37	4.42	0.70	0.46	0.46	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	51.88	4.05	1.35	0.81	1.62	0.81	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	59.71	9.25	6.73	1.26	2.52	0.84	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	445.39	111.35	155.89	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	60.56	9.93	9.93	0.00	1.49	1.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	46.83	7.04	7.31	0.00	0.81	2.71	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	60.75	4.76	2.72	0.91	1.13	0.45	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	53.40	1.31	2.12	1.31	1.80	1.14	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	68.71	7.11	6.74	0.91	1.64	0.73	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	50.92	6.90	6.37	0.53	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	39.62	6.00	7.80	0.60	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	86.97	20.35	14.44	2.63	1.97	1.97	0.33	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	54.32	6.83	2.44	0.98	0.65	0.81	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	68.26	7.41	7.76	1.59	2.12	0.71	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	47.82	4.92	6.33	0.00	2.81	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	51.95	1.38	2.30	0.00	1.38	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	45.95	4.18	2.25	1.61	3.21	0.96	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	126.57	31.73	10.00	1.38	1.38	0.69	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	417.19	55.63	32.87	7.59	5.06	10.11	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	62.83	7.35	5.12	1.56	2.45	0.89	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	46.15	6.35	3.39	0.42	0.42	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	47.71	5.22	3.80	0.71	1.42	2.14	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	76.41	5.15	3.43	2.58	3.00	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	884.72	153.47	108.33	36.11	18.06	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	46.65	3.67	2.00	1.00	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	48.24	4.06	1.35	0.90	0.45	0.45	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	53.96	9.13	3.97	0.79	1.19	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	47.36	2.79	0.93	0.00	2.79	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	68.11	4.16	3.03	1.14	3.03	0.00	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	71.04	7.50	1.96	1.63	1.30	0.98	0.00	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	42.27	1.74	0.44	0.87	1.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	68.75	13.12	4.98	1.81	0.90	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	54.68	9.70	5.29	2.65	1.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	63.16	3.99	2.66	0.00	1.99	1.99	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	56.05	4.96	2.98	1.49	1.98	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	72.35	6.13	4.21	0.00	2.68	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	86.50	3.63	1.81	1.51	3.02	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	78.68	11.05	7.29	1.55	1.11	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	54.89	7.45	6.10	2.03	1.36	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	480.30	56.20	30.66	5.11	15.33	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	57.31	5.49	3.05	1.22	1.83	2.44	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	61.37	5.35	2.83	0.31	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	55.08	1.51	1.21	0.91	0.91	1.51	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	64.87	7.91	3.16	2.37	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	139.44	27.21	22.67	3.40	1.13	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	424.86	60.69	35.41	30.35	10.12	15.17	5.06	5.06
Myoblast, donor1	11241-116D8	102.36	25.47	11.80	1.86	0.87	1.61	0.25	0.25
Myoblast, donor2	11322-117D8	77.87	10.93	6.52	6.14	4.41	3.64	0.19	0.58
Myoblast, donor3	11398-118D3	103.59	11.44	7.40	4.54	3.03	1.68	0.34	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	40.28	0.58	0.58	10.94	8.17	2.77	1.90	0.88
Natural Killer Cells, donor1	11230-116C6	37.82	5.84	0.31	6.15	3.69	6.77	0.62	0.00
Natural Killer Cells, donor2	11311-117C6	50.36	5.73	1.51	4.52	5.43	6.63	1.81	0.30
Natural Killer Cells, donor3	11387-118C1	43.44	5.71	3.87	3.68	2.21	3.87	2.58	0.00
Neural stem cells, donor1	11275-116H6	166.23	14.52	6.53	9.80	14.15	7.98	0.73	1.45
Neural stem cells, donor2	11352-117H2	113.61	9.63	5.78	26.96	13.48	23.11	3.85	1.93
Neurons, donor1	11494-119E9	70.55	1.14	0.00	14.79	21.62	7.97	1.14	1.14
Neurons, donor2	11574-120E8	65.39	2.20	0.88	9.69	16.73	6.60	1.76	2.20
Neurons, donor3	11655-122E8	64.13	4.11	0.82	6.58	14.80	7.40	2.47	1.64
Neutrophils, donor1	11233-116C9	94.66	24.13	10.21	2.78	0.00	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	40.58	2.90	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	151.49	53.14	24.43	4.89	3.05	1.22	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	118.74	16.50	14.72	3.80	2.37	6.89	0.95	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	62.84	10.42	5.21	0.00	1.30	1.95	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	56.36	10.03	7.22	1.40	0.40	1.00	0.60	0.00
Olfactory epithelial cells, donor1	11933-125I7	73.09	13.90	7.85	0.28	1.38	0.55	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	79.75	15.49	10.13	1.01	0.87	0.29	0.14	0.29
Olfactory epithelial cells, donor3	11935-125I9	88.53	11.35	5.22	0.79	1.48	0.45	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	99.73	14.22	7.69	1.56	2.34	0.88	0.19	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	134.81	19.86	10.23	4.21	7.22	0.60	0.00	1.81
Osteoblast - differentiated, donor1	11276-116H7	85.93	13.19	8.93	0.85	2.13	1.06	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	53.73	6.86	6.86	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	43.45	4.97	3.10	0.62	1.24	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	89.31	16.42	7.23	2.35	1.95	2.15	0.59	0.00
Osteoblast, donor2	11354-117H4	141.87	24.58	18.96	4.21	0.70	1.40	0.70	0.00
Osteoblast, donor3	11426-118G4	107.17	14.22	10.66	1.96	1.96	0.71	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	112.45	19.29	13.90	3.03	2.11	1.43	0.08	0.08
Pericytes, donor1	11491-119E6	76.44	5.34	2.45	1.67	0.89	1.34	0.22	0.22
Pericytes, donor2	11571-120E5	64.74	4.07	3.85	1.58	0.91	0.45	0.91	0.00
Pericytes, donor3	11652-122E5	111.49	9.16	4.07	3.05	0.61	0.81	0.20	0.00
Perineurial Cells, donor1	11499-119F5	127.83	14.24	11.87	3.50	3.05	1.13	0.45	0.34
Perineurial Cells, donor2	11579-120F4	103.70	11.32	5.80	0.92	2.12	1.29	0.18	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	49.40	2.87	0.96	1.91	4.14	3.51	1.27	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	37.71	4.16	1.96	1.71	1.96	2.94	0.73	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	38.44	2.07	1.42	4.01	2.20	2.07	0.91	0.26
Placental Epithelial Cells, donor1	11278-116H9	80.60	9.33	2.15	8.61	5.26	1.20	0.96	0.72
Placental Epithelial Cells, donor2	11355-117H5	98.69	17.74	11.09	2.22	1.11	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	105.43	10.99	6.68	1.96	0.20	0.39	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	66.45	12.03	6.65	0.32	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	113.12	21.38	5.06	1.31	0.75	0.56	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	158.72	25.71	12.53	2.22	2.09	1.17	0.13	0.39
Preadipocyte - breast, donor2	11328-117E5	105.37	17.56	8.33	0.23	0.45	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	122.76	23.76	8.95	2.56	1.07	0.96	0.11	0.32
Preadipocyte - omental, donor2	11329-117E6	121.34	28.37	10.04	1.31	2.18	0.44	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	102.71	14.47	9.17	2.01	1.43	1.29	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	100.40	14.76	5.91	0.98	0.00	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	73.40	14.74	6.76	0.92	0.31	0.61	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	131.39	12.40	9.74	4.07	3.72	2.48	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	96.55	18.05	12.94	1.70	0.68	0.68	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	158.72	18.72	8.20	3.54	1.77	2.98	0.28	0.37
Preadipocyte - visceral, donor2	11357-117H7	119.19	17.49	17.49	1.84	0.46	0.92	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	83.49	12.64	5.43	2.19	0.84	1.25	0.10	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	158.70	20.67	3.77	12.37	4.83	5.58	1.36	0.75
Prostate Epithelial Cells, donor2	11331-117E8	117.27	21.26	11.24	3.66	0.95	2.30	0.14	0.27
Prostate Epithelial Cells, donor3	11404-118D9	100.98	2.27	1.47	8.94	4.90	1.65	0.18	0.18
Prostate Stromal Cells, donor1	11254-116F3	93.51	17.54	15.95	3.42	2.39	2.39	0.11	0.57
Prostate Stromal Cells, donor2	11332-117E9	95.92	10.94	7.17	3.59	3.23	0.90	0.18	0.36
Prostate Stromal Cells, donor3	11405-118E1	80.81	13.45	9.80	1.36	0.63	0.73	0.21	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	62.41	8.39	2.19	1.82	8.03	1.46	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	77.63	5.68	3.12	4.99	4.09	2.43	0.21	0.28
Renal Epithelial Cells, donor1	11517-119H5	49.20	0.51	1.52	2.54	3.55	2.03	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	63.31	2.85	3.56	2.13	2.85	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	104.91	12.28	4.98	5.19	2.96	2.01	1.16	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	53.79	2.04	2.72	0.68	0.68	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	86.92	5.39	2.43	2.43	1.75	1.35	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	64.38	8.44	3.77	2.44	2.89	2.00	0.22	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	48.58	2.00	0.00	1.33	0.00	0.67	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	81.21	5.72	4.18	2.42	4.84	2.64	0.22	0.44
Renal Mesangial Cells, donor2	11598-120H5	72.10	8.78	5.64	1.88	3.76	3.13	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	40.78	2.77	3.33	0.55	3.05	0.55	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	112.20	7.52	3.76	6.71	8.86	3.49	0.81	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	70.00	4.64	3.37	2.95	2.95	0.42	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	70.58	2.89	2.12	1.93	5.01	1.35	0.39	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	119.01	10.11	4.41	7.00	5.70	3.37	1.04	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	100.91	12.79	7.39	1.42	3.70	2.84	0.00	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	79.24	1.03	1.03	1.03	3.09	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	73.52	9.28	2.76	4.27	2.01	4.77	2.26	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	141.79	15.90	6.15	4.54	3.47	2.94	0.94	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	49.14	0.89	0.89	0.89	0.89	1.79	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	62.19	5.50	4.40	4.40	8.81	1.65	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	60.91	2.90	1.74	1.74	3.48	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	46.42	3.38	1.43	2.47	3.12	0.91	0.52	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	40.62	1.29	1.09	2.58	3.97	0.99	0.10	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	61.79	3.57	1.23	3.68	4.02	1.23	0.11	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	67.60	4.34	1.98	3.85	4.22	1.98	0.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	47.90	3.96	1.86	3.15	5.01	0.58	0.00	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	53.62	2.77	0.69	2.77	3.93	0.46	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	38.20	2.05	0.96	0.82	2.33	0.68	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	43.87	2.72	1.06	2.87	4.39	1.51	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	46.41	3.23	0.72	2.87	3.76	1.43	0.00	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	51.21	2.01	0.86	1.58	2.01	0.72	0.14	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	44.54	2.47	1.07	1.40	3.97	1.61	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	53.33	3.10	0.89	1.77	5.97	1.11	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	38.62	2.87	2.10	1.53	0.57	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	41.08	2.05	1.12	1.49	3.45	0.65	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	67.83	4.51	1.32	4.32	3.57	3.19	0.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	35.96	2.39	0.53	1.19	1.86	1.46	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	43.12	1.85	0.97	3.11	2.63	1.07	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	52.32	3.25	0.76	3.44	4.39	1.15	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	35.67	2.14	0.96	0.64	2.03	0.85	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	36.44	2.24	0.84	2.24	1.68	1.12	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	49.39	2.39	0.68	2.22	2.91	0.85	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	32.27	2.37	1.09	1.28	1.09	0.36	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	44.52	3.56	0.98	2.21	3.92	1.47	0.12	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	51.58	3.90	1.21	2.15	2.96	1.07	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	54.25	2.83	0.94	2.12	1.89	1.18	0.47	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	47.02	1.98	1.39	2.18	3.97	0.60	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	50.98	3.51	1.17	3.04	3.27	1.17	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	44.37	3.11	1.04	1.24	1.87	0.21	0.62	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	45.13	4.65	0.88	1.99	2.65	1.33	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	43.87	3.13	1.88	1.46	3.13	0.84	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	50.20	3.77	1.08	2.69	3.10	0.81	0.13	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	28.27	1.70	0.34	0.85	2.90	1.02	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	47.04	1.74	0.77	1.74	2.89	0.96	0.19	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	47.45	1.89	1.38	1.38	1.20	1.03	0.00	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	36.49	1.65	1.37	0.96	2.88	1.23	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	46.95	1.31	2.46	1.81	2.96	0.82	0.00	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	36.30	1.53	1.02	1.36	3.92	1.02	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	51.05	2.52	1.92	1.78	2.81	1.48	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	40.25	1.33	1.07	3.47	2.67	0.53	0.53	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	40.24	2.63	0.69	2.35	1.66	0.83	0.41	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	46.19	1.43	1.19	1.43	5.48	1.67	0.24	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	56.23	2.42	1.61	2.82	8.26	0.81	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	47.09	3.58	2.35	1.98	2.64	0.85	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	43.32	4.54	2.45	1.75	4.54	1.40	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	42.91	2.42	1.81	1.81	3.93	0.91	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	46.63	3.30	1.84	1.71	1.10	0.24	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	62.59	5.82	3.78	2.62	4.22	1.75	0.44	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	43.81	3.04	1.22	0.00	5.48	1.83	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	42.50	2.71	0.60	1.21	1.51	1.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	57.68	3.62	0.23	2.04	3.85	1.81	0.45	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	67.40	3.59	1.80	3.00	4.79	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	55.38	3.07	1.89	2.48	3.19	1.18	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	46.74	3.20	1.07	3.20	4.48	0.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	39.66	1.80	0.60	0.00	1.80	3.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	66.77	4.51	2.63	1.88	0.56	1.32	0.38	0.00
Schwann Cells, donor2	11578-120F3	85.06	0.00	0.00	3.40	10.21	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	80.18	6.79	6.57	1.97	1.75	0.66	0.00	0.00
Sebocyte, donor1	11220-116B5	310.59	21.91	8.22	6.03	3.29	1.64	0.00	0.55
Sebocyte, donor2	11301-117B5	128.22	11.03	6.43	4.60	2.30	1.38	0.00	0.46
Sebocyte, donor3	11378-118B1	115.22	5.15	2.89	2.27	1.44	1.24	0.21	0.00
Sertoli Cells, donor1	11255-116F4	132.53	33.13	6.63	1.66	3.31	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	115.80	19.77	11.30	0.00	2.82	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	100.82	7.74	4.22	4.49	4.31	4.13	1.23	0.79
Skeletal Muscle Cells, donor2	11358-117H8	26.75	5.06	1.45	0.72	2.17	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	79.42	6.69	1.67	2.51	0.84	3.34	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	89.39	7.07	5.03	3.61	1.57	0.94	0.31	0.31
Skeletal Muscle Cells, donor5	11455-119A6	84.88	5.50	4.31	3.42	2.97	1.78	0.59	0.59
Skeletal Muscle Cells, donor6	11459-119B1	114.81	7.23	2.15	5.54	2.46	1.69	0.46	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	141.38	10.08	5.54	4.28	2.65	2.52	0.25	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	120.86	6.14	3.71	1.28	1.85	1.85	0.29	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	94.15	4.66	2.68	6.15	4.27	3.87	0.50	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	142.64	14.07	6.15	4.04	3.45	2.53	0.67	0.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	47.04	5.07	0.72	2.90	1.45	1.45	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	54.90	8.39	6.88	0.69	0.69	0.55	0.28	0.00
Skin - palm, donor1	10286-104F7	59.09	0.00	5.37	0.00	2.69	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	88.08	6.49	3.32	1.87	1.44	0.29	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	350.06	40.08	12.27	10.63	6.54	2.45	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	61.93	5.84	1.43	1.56	1.17	0.39	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	134.42	15.43	9.45	5.42	2.50	1.39	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	98.04	13.50	4.36	2.53	4.50	0.56	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	182.69	13.74	5.07	5.50	6.13	1.69	0.42	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	109.28	6.82	2.32	5.47	5.70	1.42	0.15	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	102.76	19.13	13.27	0.93	0.31	0.62	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	118.28	18.68	12.45	1.56	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	78.18	14.70	4.70	2.35	1.18	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	92.37	11.93	7.96	2.43	2.87	1.10	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	96.48	16.93	7.09	1.58	0.79	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	88.07	15.45	10.04	0.00	1.55	1.55	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	67.05	4.00	3.00	4.00	2.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	95.15	18.50	12.11	1.46	1.33	0.53	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	66.94	5.98	6.21	2.66	1.99	0.66	0.00	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	86.42	19.20	8.83	1.41	0.26	0.64	0.13	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	95.72	11.72	6.84	0.98	1.30	2.60	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	122.86	17.13	6.50	2.95	3.54	1.18	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	95.67	13.52	5.27	0.71	1.00	0.85	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	84.10	5.69	1.63	1.63	0.65	0.33	0.16	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	44.75	3.04	3.04	1.83	2.44	1.83	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	75.01	12.38	9.60	2.78	0.51	0.76	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	24.48	12.24	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	63.42	17.64	9.54	0.48	0.48	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	96.30	9.73	4.28	1.62	2.06	1.03	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	69.31	6.24	3.44	1.08	1.51	1.29	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	78.93	5.04	2.94	2.10	3.36	0.94	0.10	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	99.46	15.31	13.15	2.32	2.63	1.08	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	73.30	17.25	8.62	0.00	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	83.38	15.54	3.89	0.90	0.30	0.30	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	72.72	5.80	2.05	1.02	1.71	1.02	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	116.69	7.70	3.53	1.81	2.12	2.12	0.31	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	135.06	30.09	17.21	5.64	2.21	1.91	0.40	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	116.96	21.85	12.06	2.28	1.82	0.46	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	82.72	22.34	4.83	3.02	0.00	1.21	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	128.22	11.13	7.95	7.42	4.50	2.65	0.79	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	110.79	22.37	8.79	3.60	1.33	1.46	0.53	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	91.03	13.90	12.15	2.25	1.38	1.38	0.25	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	98.93	14.71	9.89	2.28	2.28	2.03	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	108.41	19.00	9.65	2.26	1.36	0.90	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	63.76	8.25	3.75	1.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	127.93	1.29	0.00	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	106.97	14.88	3.72	3.72	1.40	0.47	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	99.46	25.24	21.21	2.52	1.01	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	85.87	19.12	15.67	1.57	0.31	0.63	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	69.32	5.01	2.95	0.59	1.47	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	112.80	8.66	4.75	5.25	5.00	3.00	0.58	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	61.67	7.47	3.74	2.34	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	93.40	19.57	7.20	3.02	2.01	1.58	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	97.65	10.45	5.10	2.04	1.27	1.02	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	69.01	9.03	5.45	0.94	2.26	0.38	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	135.97	13.56	11.04	4.33	2.79	1.96	0.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	105.15	15.58	13.24	1.93	1.68	1.84	0.34	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	56.19	3.33	0.48	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	98.84	15.66	6.85	2.94	1.96	0.49	0.24	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	118.87	25.85	19.66	2.43	0.44	1.10	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	77.24	10.83	5.85	3.80	2.63	1.76	0.59	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	66.67	2.72	0.78	2.92	0.97	1.55	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	65.85	13.49	3.44	0.53	1.32	0.26	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	65.09	12.65	9.67	1.12	2.23	2.98	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	91.99	22.64	10.06	1.80	0.72	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	66.43	13.63	5.68	1.42	0.57	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	94.13	9.06	4.73	1.58	2.36	2.36	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	72.38	11.68	4.83	0.25	0.51	0.25	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	78.27	9.58	4.39	1.60	1.20	1.20	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	69.39	5.43	2.51	0.42	0.42	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	60.96	4.58	2.75	1.83	0.00	0.92	0.92	0.00
Synoviocyte, donor1	11291-117A4	130.45	41.74	15.49	1.85	1.68	1.51	0.00	0.34
Synoviocyte, donor2	11368-117I9	89.68	10.90	10.06	1.68	1.01	0.84	0.00	0.00
Synoviocyte, donor3	11440-118H9	65.01	9.83	3.35	0.00	0.89	0.67	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	130.07	8.93	5.00	5.36	5.36	3.22	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	57.48	5.95	5.95	0.00	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	78.26	3.70	4.40	1.85	2.32	1.62	0.00	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	94.34	5.81	2.29	4.23	2.80	1.79	0.14	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	57.21	3.48	2.32	0.77	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	60.13	6.30	4.58	2.29	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	137.91	17.59	7.14	5.04	4.92	1.23	0.37	0.12
Urethra, donor2	10319-105A4	43.16	0.00	0.00	0.00	0.00	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	109.98	7.44	2.39	3.72	1.86	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	84.52	3.61	1.20	3.20	3.20	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	72.20	3.44	1.15	0.46	0.69	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	176.76	13.60	6.69	3.12	3.12	0.22	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	41.82	1.78	1.78	4.45	2.67	4.45	2.67	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	55.75	0.00	0.00	5.72	4.29	5.72	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	30.12	2.05	0.00	6.85	8.21	3.42	1.37	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	30.65	1.03	1.38	5.51	4.13	2.41	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	34.28	1.16	0.00	5.23	2.32	8.13	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	55.19	0.00	1.04	6.25	5.21	4.16	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	69.75	4.59	0.00	4.59	3.67	1.84	2.75	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	26.47	1.83	0.00	1.83	6.39	3.65	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	72.29	13.20	5.67	4.69	4.44	3.21	0.74	0.49
Wilms' tumor cell line:HFWT	10597-108E3	44.88	0.88	0.00	1.76	0.88	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	146.92	22.90	6.14	5.59	7.26	3.63	0.28	0.84
achilles tendon, donor2	10292-104G4	35.13	2.07	0.00	4.13	2.07	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	90.00	2.55	0.00	15.30	10.45	8.67	2.29	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	46.43	0.93	0.00	17.41	19.73	6.97	2.09	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	119.66	1.07	0.83	4.39	6.17	4.04	1.07	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	69.39	0.00	0.00	9.25	14.69	2.72	2.99	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	94.44	3.65	0.84	7.59	11.52	4.78	0.84	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	83.96	2.75	1.27	2.33	5.29	1.06	0.00	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	112.97	16.33	3.54	2.99	3.81	1.63	0.00	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	73.59	0.44	0.88	7.93	7.93	1.76	0.44	3.53
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	86.16	2.86	0.82	3.68	11.84	3.68	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	28.35	0.00	0.39	5.44	4.27	3.11	0.39	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	56.67	1.66	0.37	4.60	9.02	1.29	0.18	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	89.71	7.80	0.00	0.00	3.90	7.80	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	113.63	5.34	4.42	1.63	2.79	0.70	0.46	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	68.09	0.52	0.52	4.66	5.44	3.11	0.52	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	80.66	1.46	0.00	3.80	5.55	1.46	0.00	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	53.45	4.18	3.25	2.79	3.25	0.93	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	60.87	2.47	1.23	3.29	7.40	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	40.52	0.61	0.92	2.15	6.14	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	115.64	5.55	4.27	4.69	12.80	2.13	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	95.84	6.98	2.12	4.85	13.34	2.12	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	123.72	8.67	4.09	6.26	8.18	2.65	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	75.95	1.34	0.67	5.57	8.91	3.34	1.34	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	88.39	10.34	7.34	7.34	4.67	3.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	89.19	5.57	3.72	3.72	3.72	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	145.77	10.92	3.77	7.53	2.26	4.90	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	98.57	7.85	6.98	1.31	3.05	1.31	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	80.60	1.87	3.75	7.50	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	93.49	8.01	4.00	0.94	3.53	1.18	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	88.57	3.57	1.86	2.64	1.86	1.40	0.62	0.16
adipose, donor1	10184-103D4	131.94	7.04	5.86	19.94	8.21	14.07	2.93	2.35
adipose, donor2	10185-103D5	38.93	2.43	1.62	2.03	3.65	1.62	0.41	0.00
adipose, donor3	10186-103D6	47.38	6.26	3.81	3.81	2.18	4.63	1.09	0.00
adipose, donor4	10187-103D7	42.47	6.07	2.60	10.40	7.80	3.47	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	52.08	0.47	0.16	4.89	6.15	3.16	0.47	0.16
adrenal gland, adult, pool1	10081-102A9	47.29	0.00	7.28	3.64	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	115.93	5.60	1.20	6.14	10.14	2.67	0.27	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	90.75	0.71	0.36	3.22	4.64	1.07	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	121.72	22.03	14.14	1.85	1.62	1.16	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	155.19	15.89	10.82	2.03	0.00	3.04	1.01	0.00
amniotic membrane cells, donor3	12237-129G5	106.35	9.13	5.30	2.06	0.29	0.59	0.00	0.00
amygdala - adult, donor10196	10167-103B5	94.86	4.74	2.37	4.74	5.93	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	66.51	1.01	1.62	4.46	7.91	3.04	1.22	0.41
amygdala, newborn, donor10223	10360-105E9	54.55	1.61	0.32	2.58	6.13	3.55	0.65	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	156.11	21.39	12.61	6.88	4.58	3.44	0.64	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	105.24	4.63	2.43	9.93	3.09	1.32	0.44	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	90.52	7.68	3.01	4.34	4.01	4.68	1.00	0.67
aorta, adult, pool1	10052-101G7	86.69	2.16	1.57	0.78	1.57	1.77	0.39	0.20
appendix, adult	10189-103D9	58.99	2.72	0.39	2.72	3.88	3.88	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	59.16	22.70	8.60	4.13	6.88	8.60	1.03	1.38
artery, adult	10190-103E1	59.78	1.36	0.00	1.36	1.36	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	80.84	7.53	3.77	4.64	1.59	0.87	0.14	0.00
b cell line:RPMI1788	10427-106D4	276.29	20.67	3.42	13.68	11.00	11.00	2.83	1.93
basal cell carcinoma cell line:TE 354.T	10702-109G9	119.02	30.52	21.92	3.05	1.39	1.94	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	145.37	13.40	6.35	10.02	4.86	3.47	0.50	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	270.48	8.03	3.01	16.40	9.21	2.34	0.33	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	50.89	1.12	0.00	3.36	5.03	0.00	0.56	0.56
bladder, adult, pool1	10011-101C2	72.36	3.26	1.20	1.52	2.93	1.20	0.33	0.00
blood, adult, pool1	10053-101G8	6.64	4.43	0.00	4.43	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	61.66	9.42	10.28	0.00	0.00	0.00	0.00	0.86
bone marrow, adult	10192-103E3	81.65	6.75	2.70	1.35	0.67	0.67	0.00	0.67
brain, adult, donor1	10084-102B3	48.18	1.03	0.00	3.08	5.13	1.03	0.00	2.05
brain, adult, pool1	10012-101C3	69.49	3.45	1.45	3.79	6.57	3.45	0.78	0.56
brain, fetal, pool1	10085-102B4	82.81	0.00	0.00	5.34	5.34	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	77.31	5.29	0.66	1.32	4.96	2.97	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	119.33	6.87	3.25	5.62	7.24	2.87	0.75	0.75
breast, adult, donor1	10080-102A8	61.24	2.53	1.26	1.26	3.79	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	147.36	6.22	2.41	3.56	6.61	3.81	0.76	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	66.48	7.42	3.71	3.09	5.88	1.55	0.31	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	130.07	9.67	14.73	1.61	1.61	1.84	0.23	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	138.47	10.41	3.87	3.63	6.05	1.21	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	75.70	0.94	0.00	2.82	6.58	3.29	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	63.22	8.64	3.28	5.36	4.48	2.63	0.22	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	112.18	1.27	0.63	9.19	17.75	6.97	0.32	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	109.13	4.26	2.40	4.79	10.38	7.72	1.33	0.80
caudate nucleus - adult, donor10196	10177-103C6	69.08	8.06	0.00	8.06	14.97	4.61	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	59.40	1.51	0.84	8.37	8.53	3.85	0.33	0.50
caudate nucleus, adult, donor10258	10379-105H1	90.93	2.29	0.00	5.35	9.17	5.35	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	57.86	1.46	1.10	9.89	10.25	9.16	1.10	2.93
cerebellum - adult, donor10196	10173-103C2	145.66	0.00	2.91	2.91	17.48	8.74	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	93.52	2.78	1.07	9.18	11.32	8.54	1.92	0.64
cerebellum, adult, pool1	10083-102B2	67.61	0.69	1.38	4.14	6.55	3.45	1.38	1.03
cerebellum, newborn, donor10223	10357-105E6	102.13	2.49	0.83	4.15	12.45	8.30	1.66	1.66
cerebral meninges, adult	10188-103D8	54.21	2.27	1.51	2.27	3.03	2.02	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	48.97	3.65	0.73	0.00	0.73	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	151.55	12.94	3.02	6.18	4.60	1.73	0.29	0.43
cervical cancer cell line:ME-180	10553-107I4	158.09	17.23	6.96	11.27	4.97	1.49	0.00	0.50
cervix, adult, pool1	10013-101C4	86.51	4.30	2.52	3.15	3.78	2.94	0.73	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	169.02	24.38	6.69	15.88	8.64	4.32	0.56	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	39.19	1.31	1.31	0.00	1.31	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	185.79	5.47	1.86	11.81	10.19	4.72	0.12	1.12
choriocarcinoma cell line:SCH	10785-110H2	75.16	8.01	3.45	9.61	3.82	3.20	1.36	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	59.77	0.71	0.71	5.46	11.62	3.56	1.19	0.47
chorionic membrane cells, donor1	12238-129G6	116.53	12.25	7.12	1.42	1.99	0.57	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	169.23	26.65	20.98	3.98	2.29	1.09	0.20	0.30
chorionic membrane cells, donor3	12240-129G8	173.64	9.34	4.95	2.20	1.10	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	39.38	1.01	0.00	15.15	9.09	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	69.35	3.46	1.15	4.23	5.76	0.77	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	61.24	5.70	1.27	2.11	2.96	1.48	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	75.24	3.60	1.80	6.16	4.62	0.77	0.51	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	86.35	6.77	2.90	4.60	7.98	3.63	0.73	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	91.22	6.52	3.46	5.70	6.92	2.65	0.20	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	74.20	9.72	2.65	7.36	6.48	3.24	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	109.98	6.52	1.82	5.47	4.95	3.39	0.00	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	159.09	11.20	3.89	4.57	2.97	2.97	0.23	0.69
clear cell carcinoma cell line:TEN	10636-108I6	144.53	36.44	10.58	4.16	2.08	1.39	0.87	0.69
colon carcinoma cell line:CACO-2	10513-107D9	177.55	25.99	7.32	4.03	3.48	1.65	0.37	0.18
colon carcinoma cell line:COLO-320	10420-106C6	136.83	12.54	11.78	8.74	20.14	8.36	1.90	1.52
colon, adult, donor1	10082-102B1	85.68	3.57	1.19	1.19	3.57	2.38	0.00	1.19
colon, adult, pool1	10014-101C5	82.84	16.45	4.82	3.64	1.65	2.23	0.47	0.12
colon, fetal, donor1	10070-101I7	111.24	8.03	1.85	2.47	4.33	2.47	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	82.50	4.58	0.00	0.00	4.58	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	202.69	51.42	11.90	12.32	8.07	2.12	0.00	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	113.65	28.22	10.41	4.08	3.62	1.36	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	134.81	32.29	9.87	3.95	5.08	1.13	0.00	0.71
corpus callosum, adult, pool1	10042-101F6	98.18	4.86	2.99	9.62	12.16	8.29	2.76	2.21
cruciate ligament, donor2	10295-104G7	58.35	5.67	1.62	1.62	5.67	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	81.06	2.41	3.21	4.82	1.61	0.80	0.80	0.00
diencephalon, adult	10193-103E4	56.64	1.20	1.68	3.84	7.68	1.44	1.20	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	50.06	0.69	0.46	5.97	5.51	3.90	1.15	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	185.92	11.28	2.82	6.67	5.90	1.03	0.00	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	93.40	10.59	3.61	3.61	1.93	1.44	0.00	0.24
ductus deferens, adult	10196-103E7	91.69	29.90	13.95	2.49	2.49	1.99	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	122.42	10.08	10.08	1.44	0.00	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	141.24	9.56	8.83	6.62	0.74	5.15	0.74	0.74
dura mater, adult, donor1	10041-101F5	94.98	19.57	13.46	1.90	2.81	2.31	0.41	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	61.51	3.11	0.44	19.54	3.55	4.66	0.00	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	77.52	3.30	0.29	10.46	5.02	7.59	0.72	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	39.46	2.47	3.70	0.00	3.70	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	56.91	2.12	2.72	0.61	2.72	0.61	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	43.53	1.85	3.09	1.85	4.32	0.31	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	66.99	0.00	2.63	1.31	2.63	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	212.18	36.87	17.77	7.37	6.37	5.03	0.67	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	148.98	5.62	2.90	7.61	11.42	3.26	0.36	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	87.16	13.51	3.86	3.38	3.86	0.96	0.16	0.48
epidermoid carcinoma cell line:A431	10426-106D3	167.07	38.79	14.23	8.89	6.00	5.34	0.44	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	108.01	9.13	3.41	11.22	5.06	3.30	0.44	0.77
epididymis, adult	10197-103E8	76.82	8.16	6.49	2.30	1.67	1.47	0.21	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	116.03	5.32	3.73	3.55	4.97	1.77	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	60.56	27.53	10.22	1.97	1.97	1.97	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	95.54	13.50	5.37	7.47	8.91	3.28	0.52	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	81.10	12.20	5.02	4.43	5.51	1.38	0.20	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	96.46	16.02	5.94	8.07	5.83	3.70	0.67	0.78
esophagus, adult, pool1	10015-101C6	75.07	6.58	3.50	3.40	2.23	1.49	0.32	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	221.54	14.53	4.88	3.63	2.38	2.25	0.63	0.38
eye - muscle inferior rectus, donor1	10272-104E2	48.29	0.00	0.00	4.83	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	33.67	0.00	2.10	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	25.30	1.49	0.00	0.00	2.98	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	36.69	2.29	0.00	1.15	1.15	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	27.69	1.46	1.46	1.46	8.74	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	80.59	4.58	1.27	5.34	7.12	3.56	2.29	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	64.11	3.46	4.23	3.85	4.23	1.92	0.13	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	89.98	6.17	3.56	7.12	1.90	4.04	0.95	0.24
frontal lobe, adult, pool1	10040-101F4	100.95	3.94	1.31	5.44	8.63	2.81	0.84	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	227.89	18.32	6.91	12.31	10.21	5.40	0.90	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	228.96	16.82	6.03	4.85	4.48	2.01	0.27	0.55
gall bladder, adult	10198-103E9	95.85	14.97	6.28	1.93	1.93	0.97	0.48	0.48
gamma delta positive T cells, donor1	11937-126A2	49.39	0.00	0.00	6.98	4.83	8.05	2.15	0.00
gamma delta positive T cells, donor2	11938-126A3	37.72	0.75	0.75	4.86	1.49	5.60	0.75	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	114.06	28.94	16.47	3.38	3.17	1.90	0.42	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	137.52	6.38	1.35	3.48	6.38	1.16	0.00	0.77
gastric cancer cell line:AZ521	10549-107H9	151.82	14.92	8.36	9.35	8.03	4.26	0.33	0.98
gastric cancer cell line:GSS	10560-108A2	71.39	0.92	0.00	5.49	7.32	5.49	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	95.72	39.52	11.88	8.91	4.57	6.85	1.37	1.14
giant cell carcinoma cell line:LU65	10487-107B1	65.06	1.49	0.34	15.60	8.15	4.13	0.23	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	129.18	26.03	17.63	8.68	4.20	10.50	2.10	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	113.49	5.49	3.24	2.49	4.49	1.25	0.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	113.47	28.08	19.74	5.59	6.65	4.54	0.53	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	99.43	26.26	21.21	6.32	7.16	2.81	0.42	0.42
glioblastoma cell line:T98G	10485-107A8	122.07	12.80	6.95	5.74	4.30	3.86	0.77	0.88
glioma cell line:GI-1	10413-106B8	111.59	24.31	6.74	6.15	2.64	7.32	1.46	0.29
globus pallidus - adult, donor10196	10175-103C4	52.48	2.92	0.00	5.10	8.75	3.64	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	84.46	1.46	0.73	6.83	8.54	3.91	0.98	0.00
globus pallidus, adult, donor10258	10367-105F7	57.51	1.37	0.00	15.06	6.85	1.37	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	55.42	5.33	1.07	3.73	5.86	4.26	1.07	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	75.86	2.45	0.00	0.00	9.79	4.89	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	71.68	15.36	15.36	2.56	0.64	0.64	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	58.77	2.30	0.92	11.02	20.66	10.10	1.38	0.46
hIPS +CCl2, biol_rep2	14384-156C1	48.47	0.46	0.46	8.23	16.92	5.03	1.37	2.74
hIPS +CCl2, biol_rep3	14385-156C2	59.26	0.64	0.64	3.86	19.32	2.58	1.93	0.64
hIPS, biol_rep1	14380-156B6	61.80	2.87	2.87	8.62	27.31	7.19	8.62	5.75
hIPS, biol_rep2	14381-156B7	40.47	0.00	1.37	8.92	17.15	6.86	2.06	2.06
hIPS, biol_rep3	14382-156B8	71.73	4.41	2.21	4.41	8.83	6.62	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	44.25	2.30	0.86	2.87	3.45	2.01	1.15	0.86
heart - mitral valve, adult	10205-103F7	89.69	4.48	4.19	1.20	1.79	2.39	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	81.06	2.61	1.05	2.09	2.35	2.35	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	99.08	7.49	1.67	1.67	0.83	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	94.89	6.73	5.71	2.65	1.43	0.41	1.02	0.20
heart, adult, diseased, donor1	10051-101G6	102.63	7.24	3.83	3.83	1.70	1.70	1.28	0.00
heart, adult, pool1	10016-101C7	65.08	3.68	0.46	2.07	3.91	2.07	0.69	0.23
heart, fetal, pool1	10046-101G1	136.15	8.63	3.29	9.14	8.11	6.47	2.26	1.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	101.20	9.87	6.48	2.78	0.31	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	86.81	8.32	4.76	4.76	2.38	2.38	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	95.25	19.78	10.17	3.65	2.32	2.21	0.22	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	106.45	20.63	9.83	4.98	2.18	2.79	0.36	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	109.64	19.20	11.32	3.94	3.74	1.72	0.30	0.20
hepatoma cell line:Li-7	10484-107A7	125.34	24.36	8.23	5.12	2.56	2.11	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	58.09	4.82	2.81	5.83	6.03	3.22	0.40	0.90
hippocampus - adult, donor10196	10169-103B7	63.40	4.73	2.84	3.79	5.68	0.95	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	71.23	2.25	0.61	4.69	5.92	3.06	0.82	0.41
hippocampus, adult, donor10258	10374-105G5	57.76	2.49	0.50	1.00	6.97	1.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	58.86	1.76	0.35	3.88	7.40	3.52	0.70	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	77.51	3.05	2.44	19.53	15.26	17.09	3.05	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	46.93	0.59	0.20	16.69	11.78	9.43	2.36	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	53.57	2.03	0.76	14.22	13.20	10.92	2.54	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	55.82	3.38	2.82	6.20	12.97	5.07	0.56	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	56.29	4.65	2.84	11.10	10.59	7.23	2.07	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	62.26	4.93	1.14	10.63	7.59	9.11	1.52	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	63.94	10.22	5.84	4.96	3.50	6.42	1.46	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	61.18	5.17	4.52	4.31	7.54	5.39	1.08	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	76.32	7.51	6.67	5.42	5.84	5.00	1.25	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	92.82	19.42	9.95	13.26	6.39	9.23	1.42	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	81.80	12.38	7.39	10.61	8.52	6.75	1.45	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	102.34	16.83	10.10	5.39	6.73	10.77	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	46.32	0.63	0.63	11.58	12.83	7.04	1.25	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	50.60	0.00	1.47	14.25	11.30	10.32	0.98	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	89.02	0.87	0.87	17.46	9.60	15.71	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	71.78	4.39	1.15	6.68	11.26	7.45	1.53	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	61.05	4.80	2.62	6.98	12.21	7.41	2.18	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	69.47	5.50	2.00	7.50	5.00	10.49	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	43.33	4.71	1.32	2.45	6.41	3.58	1.70	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	50.93	6.37	2.27	3.18	5.91	3.18	1.82	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	46.67	5.95	1.57	3.13	5.01	3.76	0.94	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	67.93	15.35	6.70	3.43	4.41	2.12	0.65	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	60.96	15.97	10.74	4.64	2.61	3.48	1.16	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	58.29	13.15	7.47	3.59	3.89	2.09	0.30	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	52.10	2.22	0.92	15.52	12.01	8.50	2.03	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	58.77	2.57	1.14	13.41	13.12	9.70	1.43	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	75.54	0.82	2.04	20.82	13.07	20.82	2.04	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	61.97	5.63	3.17	5.28	10.56	5.28	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	60.81	5.70	2.53	6.65	8.55	5.70	0.63	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	61.13	5.45	2.72	8.17	8.17	9.99	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	57.92	6.72	4.14	3.62	5.69	3.10	1.03	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	59.77	6.64	8.63	5.31	2.66	5.31	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	51.82	12.83	5.64	3.85	1.54	6.16	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	72.35	14.83	13.55	5.88	5.62	5.11	1.28	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	75.72	17.42	10.60	9.09	3.03	5.30	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	70.24	12.43	8.40	5.38	4.37	3.70	1.68	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	40.09	0.48	0.48	14.97	14.25	6.28	1.21	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	55.26	0.89	0.00	12.92	12.03	12.48	3.12	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	45.37	2.44	0.49	12.20	12.20	10.24	0.49	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	65.71	5.20	3.06	8.56	13.14	6.42	2.75	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	250.50	32.53	16.27	94.34	32.53	68.32	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	82.07	5.63	2.98	12.24	8.27	12.58	2.32	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	66.22	6.57	4.38	4.38	6.02	6.57	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	48.13	4.70	3.62	5.43	5.07	5.43	1.09	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	41.64	4.98	1.42	4.98	6.41	6.76	1.42	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	63.25	5.97	2.39	4.77	0.00	2.39	2.39	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	95.61	19.64	14.76	12.73	7.31	7.85	1.90	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	51.72	9.70	7.81	4.85	4.85	4.31	1.89	0.27
immature langerhans cells, donor1	11904-125F5	123.01	49.88	22.28	0.73	0.73	0.48	0.48	0.24
immature langerhans cells, donor2	11905-125F6	76.84	3.17	4.75	5.54	2.38	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	106.37	3.69	2.08	4.45	7.67	3.79	1.04	1.99
keratoacanthoma cell line:HKA-1	10791-110H8	107.62	4.88	1.95	2.93	2.28	0.65	0.33	0.33
kidney, adult, pool1	10017-101C8	93.12	20.83	10.01	5.31	4.31	2.50	0.70	0.50
kidney, fetal, pool1	10045-101F9	110.77	14.85	5.23	8.28	5.23	7.64	1.49	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	130.66	31.24	14.77	3.83	0.99	0.85	0.43	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	65.94	5.81	5.67	1.24	3.59	1.11	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	67.71	11.19	1.28	8.26	2.39	2.02	0.00	0.18
left atrium, adult, donor1	10079-102A7	70.29	6.54	0.54	0.54	1.63	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	66.24	3.03	1.52	3.54	2.02	1.01	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	66.21	4.65	2.74	1.37	2.46	0.82	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	62.15	12.57	7.54	0.00	0.72	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	80.98	20.65	7.07	1.09	0.00	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	88.87	17.97	7.77	1.21	1.70	0.73	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	165.08	25.40	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	35.55	11.50	10.46	0.00	1.05	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	94.33	7.56	3.42	3.42	2.24	0.83	0.00	0.24
liposarcoma cell line:KMLS-1	10782-110G8	64.20	5.47	2.34	0.78	1.41	0.47	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	62.99	9.14	12.55	2.44	4.63	2.31	0.73	0.61
liver, adult, pool1	10018-101C9	112.63	26.90	11.02	4.86	3.40	0.81	0.16	0.00
liver, fetal, pool1	10086-102B5	81.84	8.47	3.76	3.76	3.76	2.82	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	47.83	2.77	2.04	4.08	4.81	1.60	0.00	0.44
locus coeruleus, adult, donor10252	10165-103B3	63.67	1.85	1.29	6.83	7.75	4.61	0.55	1.11
locus coeruleus, adult, donor10258	10375-105G6	66.02	3.10	1.13	2.82	5.36	2.54	1.41	0.56
locus coeruleus, newborn, donor10223	10362-105F2	95.48	8.41	4.63	7.15	9.25	5.89	1.68	1.68
lung adenocarcinoma cell line:A549	10499-107C4	114.04	20.48	5.12	3.32	3.88	1.80	0.55	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	194.41	36.54	22.75	6.89	3.45	7.58	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	140.38	10.02	4.61	2.50	3.03	1.45	0.53	0.40
lung, adult, pool1	10019-101D1	67.81	3.66	2.84	2.36	1.18	1.30	0.47	0.00
lung, fetal, donor1	10068-101I5	176.38	13.13	2.00	14.27	6.28	5.14	2.28	0.29
lung, right lower lobe, adult, donor1	10075-102A3	59.11	2.29	1.37	1.83	2.75	1.37	0.00	0.00
lymph node, adult, donor1	10077-102A5	44.50	2.37	1.42	1.89	4.26	3.31	1.89	0.47
lymphangiectasia cell line:DS-1	10727-110A7	90.52	8.33	3.95	3.29	0.88	2.85	0.22	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	29.13	1.06	0.15	6.79	6.64	5.13	0.91	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	146.11	12.74	5.10	14.44	8.49	5.10	0.85	0.85
mature adipocyte, donor1	12231-129F8	98.12	3.55	0.89	1.78	1.33	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	91.73	2.08	0.83	3.94	3.74	1.25	0.00	0.21
mature adipocyte, donor3	12233-129G1	119.01	3.56	0.71	4.74	0.95	1.42	0.47	0.00
mature adipocyte, donor4	12234-129G2	115.03	5.00	1.58	2.90	1.05	1.58	1.05	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	169.64	21.44	8.58	19.78	16.92	11.91	3.57	3.81
medial frontal gyrus - adult, donor10196	10170-103B8	101.52	4.51	3.38	2.26	11.28	0.00	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	82.21	1.47	0.74	6.25	4.78	3.68	1.10	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	66.08	2.22	1.91	1.91	8.90	0.95	0.00	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	115.15	5.12	1.28	5.54	6.40	8.96	1.71	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	89.61	1.86	1.01	3.21	4.56	1.35	0.17	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	82.56	0.64	0.42	5.73	6.58	4.03	1.27	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	88.61	1.93	1.93	0.00	3.85	1.93	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	272.72	0.00	14.35	0.00	14.35	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	67.84	0.72	0.36	4.67	5.38	3.23	1.08	0.72
medulla oblongata - adult, donor10196	10174-103C3	67.49	9.09	4.54	5.19	5.84	1.30	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	79.72	3.56	2.17	8.51	7.74	4.49	0.62	0.15
medulla oblongata, adult, pool1	10038-101F2	88.97	5.88	3.18	7.26	7.75	4.90	2.04	0.98
medulla oblongata, newborn, donor10223	10361-105F1	57.63	4.86	1.04	4.86	5.55	1.74	0.35	1.04
medulloblastoma cell line:D283 Med	10838-111E1	122.44	11.51	3.76	11.96	9.30	11.73	2.21	1.33
medulloblastoma cell line:ONS-76	10759-110E3	40.59	11.13	9.78	4.52	2.32	2.45	0.37	0.24
melanoma cell line:COLO 679	10514-107E1	82.80	2.73	2.16	10.92	7.91	4.74	0.72	0.72
melanoma cell line:G-361	10465-106H6	131.66	10.32	9.23	2.17	4.34	1.63	0.27	1.09
meningioma cell line:HKBMM	10691-109F7	73.45	5.43	5.25	1.45	1.27	0.90	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	104.86	4.41	0.88	6.17	11.46	8.81	3.52	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	94.62	3.37	1.30	5.96	10.37	3.89	1.04	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	134.10	18.87	9.97	1.99	0.61	0.31	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	99.43	24.36	11.27	1.09	0.36	0.55	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	94.42	13.25	7.87	1.66	0.00	0.83	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	91.45	13.63	10.96	0.84	0.56	0.84	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	80.69	13.09	12.71	1.54	0.39	0.58	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	121.46	17.35	11.11	2.08	0.00	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	72.43	24.03	17.85	2.23	0.86	0.69	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	137.79	18.86	10.12	0.92	0.69	1.04	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	108.50	15.52	15.39	1.46	0.66	0.80	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	117.48	16.34	8.51	2.30	0.95	0.41	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	112.67	18.78	14.51	1.85	1.14	0.71	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	79.37	23.71	13.83	1.65	0.99	0.99	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	112.50	17.30	12.87	2.49	1.11	0.69	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	120.08	13.61	8.03	1.40	1.40	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	92.69	18.78	9.60	1.22	0.41	1.02	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	70.09	20.85	11.14	0.36	0.72	1.08	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	81.10	13.14	10.76	1.24	0.72	1.45	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	83.22	19.38	11.63	1.14	0.91	1.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	129.64	28.53	14.26	5.03	1.26	0.00	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	99.53	12.85	9.41	2.99	0.75	0.75	0.00	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	100.13	28.89	19.34	1.84	0.70	0.96	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	86.89	19.14	8.10	3.68	0.74	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	90.14	17.17	16.02	0.57	3.15	0.86	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	87.15	7.58	1.26	3.37	3.37	4.21	0.84	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	79.00	5.48	7.76	0.46	0.91	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	81.85	8.70	5.88	1.53	1.28	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	95.54	10.99	5.24	1.31	0.52	0.52	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	91.19	8.63	1.85	0.92	0.62	2.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	88.96	8.94	7.06	0.47	1.18	0.47	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	91.04	11.51	8.46	1.02	0.68	0.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	88.42	7.47	9.43	0.00	1.96	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	87.12	10.66	5.56	0.00	0.93	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	94.02	11.25	6.06	2.02	2.31	0.58	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	88.35	10.93	4.46	0.89	0.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	83.64	10.09	7.69	0.24	0.48	0.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	110.73	11.73	12.47	2.93	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	82.91	8.73	8.06	0.67	0.34	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	74.10	7.37	8.19	0.82	1.23	0.82	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	92.78	13.32	7.73	0.43	0.43	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	82.03	13.67	10.94	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	72.31	15.49	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	79.25	9.42	7.79	1.30	0.97	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	69.84	13.09	8.73	1.45	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	87.43	11.73	6.93	0.53	0.53	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	67.06	5.72	7.36	1.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	78.91	10.88	4.28	1.94	0.39	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	73.46	10.49	6.30	4.20	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	78.48	6.95	0.99	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	90.58	9.53	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	71.16	7.71	5.34	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	74.33	6.09	3.66	1.22	1.22	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	72.84	12.67	3.80	0.63	1.27	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	61.39	6.55	6.21	0.69	0.00	1.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	64.48	4.30	4.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	58.55	10.33	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	55.82	6.93	2.44	0.81	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	55.61	8.74	5.56	2.38	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	43.62	2.95	1.18	0.59	1.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	52.37	3.12	3.12	0.62	0.31	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	49.46	2.67	6.68	2.67	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	53.22	1.18	3.55	0.00	3.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	71.90	5.14	2.57	0.00	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	71.59	5.51	4.13	1.38	1.38	2.07	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	69.27	2.97	2.97	0.99	1.98	0.49	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	50.47	2.24	2.24	2.24	0.00	1.12	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	67.42	4.45	1.27	0.00	0.64	1.91	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	66.09	5.24	1.21	2.82	3.63	0.40	0.40	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	65.42	2.18	2.18	2.18	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	77.29	3.80	0.00	2.53	1.27	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	83.75	7.89	6.07	1.21	1.82	1.21	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	90.38	27.11	9.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	65.89	8.24	3.29	0.00	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	83.54	4.37	2.98	0.60	2.58	0.40	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	72.69	5.84	1.95	1.95	1.62	0.97	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	91.68	4.07	6.11	2.04	4.07	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	96.71	17.02	5.42	0.77	4.64	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	153.79	13.70	4.49	18.19	31.18	4.49	0.71	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	156.84	69.04	41.93	3.01	1.85	2.09	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	188.04	17.09	4.27	8.55	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	168.00	34.11	10.89	5.45	2.06	1.44	0.10	0.31
mesothelioma cell line:Mero-25	10850-111F4	78.98	15.21	9.53	6.81	6.58	1.13	0.23	0.68
mesothelioma cell line:Mero-41	10851-111F5	165.27	32.76	11.49	2.44	1.96	2.20	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	106.51	22.36	13.73	3.10	1.33	1.55	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	115.11	15.51	7.36	6.04	2.37	0.79	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	124.94	30.47	11.40	3.74	2.21	1.36	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	160.26	17.19	6.57	3.79	0.76	1.52	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	97.31	27.74	15.53	2.28	1.66	1.04	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	98.89	15.07	8.45	3.64	2.82	1.82	0.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	81.63	30.04	30.41	2.53	0.36	0.90	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	151.52	26.82	11.10	1.88	2.56	1.20	0.17	0.51
mesothelioma cell line:NCI-H28	10845-111E8	122.14	13.49	3.82	5.60	5.60	3.56	0.76	0.25
mesothelioma cell line:No36	10857-111G2	103.41	16.31	4.89	4.89	2.28	2.61	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	190.21	42.54	11.92	3.79	3.79	2.44	0.81	0.54
migratory langerhans cells, donor1	11901-125F2	158.34	11.32	5.95	7.48	5.18	2.30	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	137.75	8.55	2.81	4.88	5.01	2.56	0.24	0.85
migratory langerhans cells, donor3	11903-125F4	143.40	8.26	1.62	4.31	4.49	1.79	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	88.15	2.29	1.63	5.88	3.92	1.63	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	123.13	7.63	10.38	4.45	1.91	0.21	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	93.06	4.38	2.53	4.38	3.92	0.69	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	50.43	4.38	3.81	0.95	1.90	1.33	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	43.98	0.74	0.00	11.27	14.60	3.88	0.92	1.48
myeloma cell line:PCM6	10474-106I6	108.52	6.52	0.99	3.95	3.36	1.58	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	59.86	8.12	4.57	0.51	1.01	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	75.71	9.22	4.12	2.55	2.16	0.59	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	112.87	4.90	1.11	10.81	7.35	1.89	0.22	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	122.67	6.55	1.54	10.88	6.32	2.50	0.15	0.44
nasal epithelial cells, donor2	12227-129F4	112.05	9.38	4.97	3.86	3.86	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	102.15	0.69	0.46	14.03	26.23	8.28	1.38	5.98
neuroblastoma cell line:NB-1	10539-107G8	146.67	9.92	3.74	9.17	15.34	6.92	0.75	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	109.66	1.90	1.05	21.09	20.88	6.12	0.84	3.37
neuroblastoma cell line:NH-12	10555-107I6	106.22	2.42	1.49	8.57	18.26	7.64	2.24	2.98
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	126.20	1.19	0.24	19.69	17.55	13.28	0.71	4.27
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	127.81	2.22	0.48	13.94	10.61	6.81	1.11	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	116.73	1.61	1.01	4.03	5.84	1.61	0.81	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	56.58	0.00	0.00	11.44	23.52	4.45	1.27	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	97.68	8.52	4.26	0.80	1.06	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	138.51	12.51	7.61	8.46	12.01	7.61	1.35	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	79.25	10.41	2.40	6.40	6.40	2.40	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	126.00	19.88	12.82	1.60	1.92	1.28	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	86.98	22.07	12.61	0.79	1.05	1.58	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	92.80	3.75	1.87	8.72	13.69	4.22	1.03	1.50
occipital cortex - adult, donor10196	10172-103C1	94.78	4.12	0.00	6.18	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	70.04	0.81	0.81	5.37	8.05	2.95	1.34	0.81
occipital cortex, newborn, donor10223	10355-105E4	78.98	0.73	0.36	2.55	4.73	1.82	0.73	1.09
occipital lobe, adult, donor1	10076-102A4	84.75	1.84	1.57	3.41	7.61	2.10	0.26	0.79
occipital lobe, fetal, donor1	10073-102A1	83.67	1.72	0.43	9.01	21.88	6.44	0.86	3.00
occipital pole, adult, pool1	10036-101E9	91.61	2.37	0.95	4.10	9.22	2.29	0.39	1.50
olfactory region, adult	10195-103E6	53.69	1.53	2.10	2.10	4.78	2.10	0.38	0.57
optic nerve, donor1	10277-104E7	88.05	0.00	0.00	8.00	20.01	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	164.03	68.69	14.24	6.83	4.44	1.82	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	114.86	8.79	2.61	3.16	5.77	0.96	0.27	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	68.75	8.64	4.23	2.37	0.85	0.85	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	145.54	13.40	7.05	5.54	3.12	2.08	0.35	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	88.48	9.41	4.12	2.65	1.76	0.59	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	114.92	6.54	0.93	8.41	6.54	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	109.42	15.69	7.21	3.39	5.73	6.57	0.85	0.42
ovary, adult, pool1	10020-101D2	74.51	3.41	0.52	6.73	7.16	3.67	0.96	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	77.54	7.33	3.48	1.28	2.20	0.73	0.55	0.55
pancreas, adult, donor1	10049-101G4	116.64	6.58	2.82	2.82	3.76	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	77.99	3.91	1.68	5.03	5.87	0.56	0.84	1.96
papillary adenocarcinoma cell line:8505C	10437-106E5	111.92	17.04	9.54	7.84	4.77	1.53	0.00	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	116.74	14.41	5.46	3.31	5.13	1.66	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	93.90	3.02	1.56	6.50	7.50	2.20	0.55	1.19
parietal cortex, adult, donor10258	10373-105G4	46.24	1.47	2.20	4.40	11.01	0.73	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	79.00	4.70	0.00	1.88	4.70	0.00	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	59.86	0.29	0.57	5.13	8.84	2.57	0.86	1.14
parietal lobe, adult, pool1	10034-101E7	91.73	4.05	1.32	6.52	9.43	3.26	0.97	0.88
parietal lobe, fetal, donor1	10072-101I9	81.47	0.97	0.97	6.79	20.37	5.82	0.97	5.82
parietal lobe, newborn, donor10223	10356-105E5	72.53	4.11	0.00	3.36	8.22	5.61	0.37	0.75
parotid gland, adult	10199-103F1	130.12	9.25	3.08	3.70	3.08	0.62	0.62	0.62
penis, adult	10200-103F2	67.68	2.69	1.07	2.69	2.15	2.15	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	51.88	0.37	0.00	28.82	6.14	6.14	2.97	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	146.42	15.74	8.74	4.81	2.77	1.75	0.73	0.15
pineal gland - adult, donor10196	10179-103C8	71.60	9.03	3.23	3.87	2.58	3.87	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	124.96	8.29	2.37	17.77	26.06	10.66	1.78	1.18
pineal gland, adult, donor10258	10377-105G8	93.43	9.41	1.25	5.64	8.15	5.64	0.63	1.25
pituitary gland - adult, donor10196	10180-103C9	158.85	27.32	8.09	3.04	4.05	6.07	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	197.53	20.85	8.86	17.20	14.59	8.86	3.65	2.08
pituitary gland, adult, donor10258	10378-105G9	103.85	18.73	5.96	4.26	11.07	5.11	1.70	0.85
placenta, adult, pool1	10021-101D3	153.94	9.35	4.62	2.90	3.66	0.86	0.65	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	89.92	6.89	2.12	10.86	9.14	6.62	1.19	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	169.80	20.23	11.36	4.36	2.49	2.02	0.16	0.31
pons, adult, pool1	10033-101E6	85.12	3.79	3.53	6.97	7.66	2.93	0.95	0.77
postcentral gyrus, adult, pool1	10032-101E5	86.83	3.05	1.74	6.36	8.11	2.70	0.44	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	75.29	0.00	2.09	2.09	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	11.02	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	126.87	9.32	3.93	7.87	8.45	2.91	0.15	0.29
prostate cancer cell line:PC-3	10439-106E7	153.19	42.29	33.94	10.71	5.45	2.90	0.36	0.36
prostate, adult, pool1	10022-101D4	65.57	2.45	1.36	4.26	4.35	1.72	0.27	0.54
putamen, adult, donor10196	10176-103C5	71.06	3.07	0.71	5.90	12.98	3.07	0.71	2.36
putamen, adult, donor10252	10152-102I8	49.02	0.00	1.96	7.84	7.84	5.88	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	48.08	2.19	0.00	8.74	15.30	2.19	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	48.81	0.72	0.72	4.59	13.53	2.66	1.21	1.93
putamen, newborn, donor10223	10365-105F5	72.72	0.75	2.25	13.49	17.99	7.50	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	96.01	19.49	6.40	2.91	3.49	0.58	0.00	0.00
rectum, fetal, donor1	10067-101I4	119.63	0.00	4.17	6.95	2.78	5.56	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	104.09	17.38	7.21	1.48	2.76	0.85	0.21	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	79.94	3.31	1.24	2.07	1.24	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	90.65	5.86	4.77	7.16	7.06	5.47	1.79	0.30
retinoblastoma cell line:Y79	10475-106I7	102.88	6.24	3.12	6.75	12.21	3.64	0.52	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	114.34	4.79	2.34	3.32	6.89	2.21	0.00	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	155.50	5.06	4.22	3.66	5.91	3.09	0.56	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	65.93	4.55	0.76	1.52	0.76	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	78.66	13.76	8.42	0.97	1.62	0.81	0.00	0.16
salivary acinar cells, donor2	11772-123I8	79.58	13.08	8.40	1.10	1.51	0.83	0.28	0.28
salivary acinar cells, donor3	11773-123I9	60.91	3.97	3.97	0.00	0.00	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	128.69	9.15	1.14	5.72	1.14	1.72	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	113.65	13.74	3.04	3.96	7.76	1.69	0.17	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	99.80	9.99	3.76	3.29	6.11	2.23	0.24	0.82
seminal vesicle, adult	10201-103F3	101.58	29.10	9.52	1.59	3.17	0.53	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	104.46	18.95	12.39	6.32	0.49	2.43	1.21	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	91.59	23.40	14.59	3.02	3.77	1.76	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	113.40	14.05	6.02	4.01	3.01	3.01	0.00	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	179.18	30.89	18.80	9.40	2.28	3.09	0.27	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	95.39	7.96	3.09	4.86	4.42	1.66	0.11	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	146.19	28.39	12.64	3.87	3.35	1.42	0.26	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	31.92	1.42	1.42	1.42	1.42	2.13	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	72.32	2.52	0.72	3.12	3.12	2.04	1.08	0.24
skeletal muscle, fetal, donor1	10066-101I3	75.38	1.01	1.01	3.02	6.03	4.02	1.01	0.00
skin, adult, donor1	10074-102A2	61.07	0.00	6.79	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	132.56	4.42	1.89	1.26	5.68	4.42	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	58.37	5.00	2.67	9.34	13.67	7.34	0.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	73.44	5.99	2.84	6.30	4.41	4.10	0.95	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	109.10	1.54	2.12	10.22	18.89	10.41	2.31	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	120.32	16.98	12.53	12.69	5.93	7.91	1.98	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	223.90	5.79	1.77	22.20	24.13	14.48	4.18	2.25
small cell lung carcinoma cell line:WA-hT	10562-108A4	126.83	8.72	5.45	7.85	15.25	2.40	0.22	1.09
small intestine, adult, pool1	10024-101D6	185.02	43.84	11.35	6.81	2.51	2.03	0.60	0.36
small intestine, fetal, donor1	10064-101I1	139.56	15.23	6.14	2.95	4.42	1.47	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	62.57	15.90	2.56	2.56	0.51	3.08	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	66.16	1.55	2.58	1.03	2.58	1.03	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	87.64	6.97	6.16	2.41	1.07	0.80	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	66.99	2.29	1.38	4.82	2.98	2.75	0.23	0.92
spinal cord, adult, donor10252	10159-103A6	57.17	1.97	1.58	7.49	5.91	5.52	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	103.08	7.61	2.08	5.53	12.45	1.38	2.08	2.08
spinal cord, fetal, donor1	10056-101H2	89.65	5.49	2.44	6.71	12.20	3.05	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	90.01	4.13	2.76	8.73	7.81	9.18	1.38	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	90.06	9.26	8.21	1.79	1.94	0.60	0.00	0.15
spleen, adult, pool1	10025-101D7	68.50	2.53	0.66	3.85	3.74	2.09	0.44	0.33
spleen, fetal, pool1	10044-101F8	80.65	3.18	1.83	5.40	5.72	3.50	1.19	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	123.59	10.04	5.90	8.07	4.87	5.49	0.93	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	150.19	27.34	7.78	3.42	2.28	1.14	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	110.43	9.78	6.29	1.40	3.15	1.05	0.35	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	64.50	5.08	0.78	0.78	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	136.53	16.10	7.54	11.14	5.18	5.40	0.79	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	180.03	3.81	0.42	5.51	6.35	1.27	1.27	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	162.04	11.42	2.54	1.69	7.19	2.54	0.85	0.00
stomach, fetal, donor1	10062-101H8	90.78	10.68	11.75	3.20	2.14	2.14	0.00	0.00
submaxillary gland, adult	10202-103F4	88.30	3.42	2.85	2.85	3.99	2.28	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	54.63	2.08	0.62	8.52	6.65	3.74	1.25	0.42
substantia nigra, adult, donor10258	10371-105G2	75.00	0.52	1.55	4.14	8.79	4.66	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	76.31	0.71	0.71	3.53	7.07	2.83	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	111.19	1.38	2.52	7.80	11.46	2.98	0.23	0.92
temporal lobe, adult, pool1	10031-101E4	80.19	3.65	1.27	3.73	6.87	2.12	0.68	0.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	92.59	1.42	1.42	7.12	18.52	7.12	3.56	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	71.64	0.88	1.32	5.71	14.07	3.52	0.88	1.32
tenocyte, donor1	11763-123H8	122.88	14.66	8.03	1.40	2.09	1.05	1.05	0.35
tenocyte, donor2	11765-123I1	86.98	9.16	3.43	1.91	2.67	1.14	0.00	0.00
tenocyte, donor3	11768-123I4	101.19	13.34	7.41	0.74	0.00	1.48	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	59.15	2.21	1.53	9.01	8.50	5.95	0.85	1.70
teratocarcinoma cell line:NCR-G1	10798-110I6	76.61	11.72	7.09	4.01	1.85	2.93	0.77	0.15
teratocarcinoma cell line:PA-1	10807-111A6	62.61	2.01	1.70	14.88	11.93	11.93	1.55	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	79.09	4.57	3.17	14.85	5.84	5.97	0.89	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	68.83	0.38	0.00	10.97	15.88	15.51	3.40	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	46.35	3.16	1.20	5.67	0.98	2.07	0.76	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	39.08	0.00	0.00	12.38	7.49	11.07	2.61	2.28
testis, adult, pool1	10026-101D8	78.17	12.56	8.16	9.34	8.16	7.73	1.40	0.43
testis, adult, pool2	10096-102C6	97.89	16.69	13.53	13.08	14.89	6.32	1.80	1.80
thalamus - adult, donor10196	10168-103B6	86.11	4.42	1.10	9.94	8.83	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	69.70	1.88	0.47	7.81	7.03	4.84	0.94	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	93.92	4.62	1.54	1.54	7.70	1.54	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	50.89	2.47	1.15	2.31	3.62	2.14	0.49	0.66
thalamus, newborn, donor10223	10366-105F6	46.60	4.03	2.30	3.45	2.88	2.30	0.58	0.00
throat, adult	10209-103G2	83.39	5.74	3.99	1.00	3.75	2.50	1.25	0.50
throat, fetal, donor1	10061-101H7	88.36	6.70	2.13	6.09	3.05	3.35	0.91	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	86.45	1.99	0.40	6.16	6.76	0.99	0.00	0.60
thymus, adult, pool1	10027-101D9	33.11	2.09	1.29	22.96	9.35	15.01	4.57	1.29
thymus, fetal, pool1	10043-101F7	54.24	3.12	1.14	22.03	8.31	15.90	3.01	2.18
thyroid carcinoma cell line:KHM-5M	10776-110G2	105.70	12.10	3.72	4.12	2.26	3.46	0.53	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	131.31	9.50	4.61	8.24	7.54	5.17	0.98	1.40
thyroid, adult, pool1	10028-101E1	117.11	9.14	3.36	7.84	6.35	3.92	0.84	0.47
thyroid, fetal, donor1	10060-101H6	117.07	8.44	5.01	1.85	2.90	1.58	1.58	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	67.75	6.16	0.00	0.00	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	89.54	8.14	4.65	3.49	4.88	2.33	0.47	0.23
tongue, fetal, donor1	10059-101H5	80.00	2.76	0.79	4.73	5.52	2.36	0.79	0.39
tonsil, adult, pool1	10047-101G2	107.89	10.92	5.81	10.12	8.92	5.61	1.00	1.30
trachea, adult, pool1	10029-101E2	80.74	10.80	4.99	3.35	3.03	1.39	0.33	0.25
trachea, fetal, donor1	10058-101H4	105.02	4.62	3.46	3.46	3.85	3.46	1.15	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	88.21	14.17	10.63	2.13	1.06	2.13	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	114.39	14.89	7.19	9.63	11.25	4.36	0.51	1.32
transitional-cell carcinoma cell line:JMSU1	10492-107B6	242.55	42.62	25.23	8.30	7.68	5.33	0.31	0.78
tridermal teratoma cell line:HGRT	10694-109G1	39.95	3.81	0.00	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	63.40	14.05	12.36	1.02	0.76	0.25	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	93.89	6.26	4.17	2.09	2.09	0.00	4.17	0.00
uterus, adult, pool1	10100-102D1	98.62	5.12	3.24	3.41	5.80	3.07	1.02	0.51
uterus, fetal, donor1	10055-101H1	108.02	7.17	4.61	2.05	6.66	1.02	0.51	0.00
vagina, adult	10204-103F6	51.70	2.58	0.00	3.23	3.23	0.65	0.65	0.65
vein, adult	10191-103E2	48.88	1.10	1.10	5.48	2.41	3.51	1.32	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	84.38	7.48	2.94	4.54	4.27	1.87	0.00	0.80

Property "Nearest transcripts" (as page type) with input value "ENST00000463568.6:-53 ENST00000676395.1:-53 ENST00000476228.5:-60 BC041600:-60 ENST00000676111.1:-116 BC001483:-124 ENST00000675243.1:-130 LF213806:-138 MA449383:-138 ENST00000240851.9:-172 NM_001195478.2:-172 NM_001195479.2:-172 NM_006070.6:-172 ENST00000674758.1:-194 ENST00000676431.1:-203 ENST00000674615.1:-204 ENST00000675420.1:-209 BC009241:-214 ENST00000479672.6:-226 ENST00000675591.1:-226 ENST00000676010.1:-226 LF210631:-230 MA446208:-230 ENST00000674798.1:-237 ENST00000675246.1:-237 ENST00000675692.1:-237 ENST00000676276.1:-237 ENST00000676054.1:-237 ENST00000675890.1:-237 ENST00000675011.1:-237 ENST00000675586.1:-237 ENST00000674645.1:-237 ENST00000675958.1:-237 AK093456:-241 ENST00000620299.5:-252 ENST00000487505.6:285 ENST00000675553.1:-304 ENST00000418917.7:-313 ENST00000674699.1:-349 ENST00000675047.1:-371 ENST00000490574.6:-371 ENST00000675543.1:-371 ENST00000676308.1:-371 ENST00000675499.1:-371 NM_001007565.2:-376 LF339557:406 MA575134:406" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.